CHINACAST EDUCATION CORPORATION Common Stock, Par Value .0001 Per Share UNDERWRITING AGREEMENT
5,930,000
Shares
CHINACAST
EDUCATION CORPORATION
Common
Stock, Par Value .0001 Per Share
December
1, 2009
Xxxx
Capital Partners, LLC
As
Representative of the several Underwriters
c/x Xxxx
Capital Partners, LLC
00
Xxxxxxxxx Xxxxx
Xxx Xxxx
Xxxxx, Xxxxxxxxxx 00000
Ladies
and Gentlemen:
1.
|
Introductory. ChinaCast
Education Corporation, a Delaware corporation (the “Company”), proposes to
sell, pursuant to the terms of this Agreement, to the several underwriters
named in Schedule A hereto (the “Underwriters,” or, each, an
“Underwriter”), on a several and not joint basis, an aggregate of
5,930,000 shares of Common Stock, $.0001 par value (the “Common Stock”) of
the Company. The aggregate of 5,930,000 shares so proposed to
be sold is hereinafter referred to as the “Firm Shares.” The
Company also proposes to sell to the Underwriters, upon the terms and
conditions set forth in Section 3 hereof, up to an additional 889,500
shares of Common Stock (the “Optional Shares”). The Firm Shares
and the Optional Shares are hereinafter collectively referred to as the
“Shares.” Xxxx Capital Partners, LLC (“Xxxx”) is acting as
representative of the several Underwriters and in such capacity is
hereinafter referred to as the
“Representative.”
|
2.
|
Representations and
Warranties.
|
The Company represents and warrants to
the several Underwriters as of the date hereof and as of each Closing
Date (as defined
below), and agrees with
the several Underwriters that:
(I) Representations
as to the Offering and the Company.
(a) A
registration statement of the Company on Form S-3 (File No. 333-153165)
(including all pre-effective amendments thereto and all post-effective
amendments thereto filed before execution of this Agreement, including, without
limitation, by virtue of the filing of the Company’s Annual Report on Form 10-K
for the year ended December 31, 2008, the “Initial Registration Statement”) in
respect of the Shares has been filed with the Securities and Exchange Commission
(the “Commission”) pursuant to Rule 415 under the Securities Act of 1933, as
amended (the “Securities Act”). The Company meets the requirements
for use of Form S-3 under the Securities Act and the rules and regulations of
the Commission thereunder (the “Rules and Regulations”). The Initial
Registration Statement and any post-effective amendment thereto, each in the
form heretofore delivered to you, and, excluding exhibits thereto, to you for
each of the other Underwriters, have been declared effective by the Commission
in such form and meet the requirements of the Securities Act and the Rules and
Regulations. The
aggregate market value of the Company’s voting and non-voting common equity held
by non-affiliates of the Company was at least $75 million within 60 days prior
to the date of filing the Initial Registration Statement and any post-effective
amendment thereto. Other than (i) a registration statement, if any,
increasing the size of the offering filed pursuant to Rule 462(b) under the
Securities Act and the Rules and Regulations (a “Rule 462(b) Registration
Statement”) and (ii) the Preliminary Prospectus (as defined below) contemplated
by this Agreement as filed pursuant to Rule 424(b) of the Rules and Regulations
and (iii) the Prospectus (as defined below) contemplated by this Agreement to be
filed pursuant to Rule 424(b) of the Rules and Regulations in accordance with
Section 4(a) hereof and (iv) any Issuer Free Writing Prospectus (as defined
below), no other document with respect to the offer and sale of the Shares has
heretofore been filed with the Commission. No stop order suspending
the effectiveness of the Initial Registration Statement, any post-effective
amendment thereto or the Rule 462(b) Registration Statement, if any, has been
issued and no proceeding for that purpose or pursuant to Section 8A of the
Securities Act has been initiated or threatened by the Commission (any
preliminary prospectus included in the Initial Registration Statement or filed
with the Commission pursuant to Rule 424(b) of the Rules and Regulations is
hereinafter called a “Preliminary Prospectus”). The various parts of
the Initial Registration Statement and the Rule 462(b) Registration Statement,
if any, in each case including all exhibits thereto and including (i) the
information contained in the Prospectus filed with the Commission pursuant to
Rule 424(b) of the Rules and Regulations and deemed by virtue of Rules 430A,
430B and 430C under the Securities Act to be part of the Initial Registration
Statement at the time it became effective and (ii) the documents incorporated by
reference in the Rule 462(b) Registration Statement at the time the Rule 462(b)
Registration Statement became effective, are hereinafter collectively called the
“Registration Statements.” The base prospectus included in the
Initial Registration Statement at the time of effectiveness thereof, as
supplemented by the final prospectus supplement relating to the offer and sale
of the Shares, in the form filed pursuant to and within the time limits
described in Rule 424(b) under the Rules and Regulations, is hereinafter
called the “Prospectus.”
- 1
-
Any
reference herein to any Registration Statement, Preliminary Prospectus or the
Prospectus shall be deemed to refer to and include the documents incorporated by
reference therein. Any reference to any amendment or supplement to
any Preliminary Prospectus or the Prospectus shall be deemed to refer to and
include any documents filed after the date of such Preliminary Prospectus or the
Prospectus under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and incorporated by reference in such Preliminary Prospectus or
Prospectus, as the case may be. Any reference to (i) any Registration
Statement shall be deemed to refer to and include the annual report of the last
completed fiscal year of the Company on Form 10-K filed under Section 13(a) or
15(d) of the Exchange Act prior to the date hereof and (ii) the effective date
of such Registration Statement shall be deemed to refer to and include the date
such Registration Statement became effective and, if later, the date such Form
10-K was so filed. Any reference to any amendment to the Registration
Statements shall be deemed to refer to and include any annual report of the
Company filed pursuant to Section 13(a) or 15(d) of the Exchange Act after the
date of this Agreement that is incorporated by reference in the Registration
Statements. If
immediately prior to the third anniversary (the “Renewal Deadline”) of the
initial effective date of the Registration Statement any of the Shares remain
unsold by the Underwriters, the Company will, prior to the Renewal Deadline
file, if it has not already done so and is eligible to do so, a new shelf
registration statement relating to the Shares, in a form reasonably satisfactory
to the Representative, and will use its best efforts to cause such registration
statement to be declared effective within 180 days after the Renewal
Deadline. The Company will take all other action necessary or
appropriate to permit the public offering and sale of the Shares to continue as
contemplated in the expired Registration Statement. References herein
to the Registration Statement shall include such new shelf registration
statement.
(b) As
of the Applicable Time (as defined below) and as of each Closing Date, as the
case may be, neither (i) the General Use Free Writing Prospectus(es) (as defined
below) issued at or prior to the Applicable Time, the Pricing Prospectus (as
defined below) and the information included on Schedule B hereto, all considered
together (collectively, the “General Disclosure Package”), (ii) any individual
Limited Use Free Writing Prospectus (as defined below), nor (iii) any electronic
road show (including any bona fide electronic road show (as defined in Rule
433(h)(5) of the Rules and Regulations that has been made available without
restriction to any person)), when considered together with the General
Disclosure Package, included or will include any untrue statement of a material
fact or omitted or will omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were
made, not misleading; provided, however, that the
Company makes no representations or warranties as to information contained in or
omitted from the Pricing Prospectus, in reliance upon, and in conformity with,
written information furnished to the Company through the Representative by or on
behalf of any Underwriter specifically for inclusion therein, which information
the parties hereto agree is limited to the Underwriter’s Information as defined
in Section 17. As used in this paragraph (b) and elsewhere in this
Agreement:
- 2
-
“Applicable
Time” means the time of this Agreement or such other time as agreed to
by the Company and the Representative.
“Pricing
Prospectus” means the Preliminary Prospectus relating to the Shares that is
included in the Registration Statement immediately prior to, or that was
conveyed to potential investors prior to, the Applicable Time, including any
document incorporated by reference therein.
“Issuer
Free Writing Prospectus” means any “issuer free writing prospectus,” as defined
in Rule 433 of the Rules and Regulations relating to the Shares in the form
filed or required to be filed with the Commission or, if not required to be
filed, in the form retained in the Company’s records pursuant to Rule 433(g) of
the Rules and Regulations.
“General
Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that is
identified on Schedule B to this Agreement.
“Limited
Use Free Writing Prospectuses” means any Issuer Free Writing Prospectus that is
not a General Use Free Writing Prospectus.
(c) No
order preventing or suspending the use of any Preliminary Prospectus, any Issuer
Free Writing Prospectus or the Prospectus relating to the proposed offering of
the Shares has been issued by the Commission, and no proceeding for that purpose
or pursuant to Section 8A of the Securities Act has been instituted or
threatened by the Commission, and each Preliminary Prospectus, at the time of
filing thereof, conformed in all material respects to the requirements of the
Securities Act and the Rules and Regulations, and did not contain an untrue
statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading; provided, however, that the
Company makes no representations or warranties as to information contained in or
omitted from any Preliminary Prospectus, in reliance upon, and in conformity
with, written information furnished to the Company through the Representative by
or on behalf of any Underwriter specifically for inclusion therein, which
information the parties hereto agree is limited to the Underwriter’s Information
as defined in Section 17.
(d) At
the respective times the Registration Statements and any amendments thereto
became or become effective, at the date of this Agreement and at each Closing
Date, each Registration Statement and any amendments thereto conformed and will
conform in all material respects to the requirements of the Securities Act and
the Rules and Regulations and did not and will not contain any untrue statement
of a material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein not misleading; and the
Prospectus and any amendments or supplements thereto, at the time the Prospectus
or any amendment or supplement thereto was issued and at each Closing Date,
conformed and will conform in all material respects to the requirements of the
Securities Act and the Rules and Regulations and did not and will not contain an
untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in light of the circumstances under
which they were made, not misleading; provided, however, that the foregoing
representations and warranties in this paragraph (d)shall not apply to
information contained in or omitted from the Registration Statements or the
Prospectus, or any amendment or supplement thereto, in reliance upon, and in
conformity with, written information furnished to the Company through the
Representative by or on behalf of any Underwriter specifically for inclusion
therein, which information the parties hereto agree is limited to the
Underwriter’s Information (as defined in Section 17). The Prospectus
contains or will contain all required information under the Securities Act with
respect to the Shares and the distribution of the Shares.
(e) Each
Issuer Free Writing Prospectus, as of its issue date and at all subsequent times
through the completion of the public offer and sale of the Shares or until any
earlier date that the Company notified or notifies the Representative as
described in Section 4(f), did not, does not and will not include any
information that conflicted, conflicts or will conflict with the information
contained in the Registration Statement, Pricing Prospectus or the Prospectus,
including any document incorporated by reference therein and any prospectus
supplement deemed to be a part thereof that has not been superseded or modified,
or included or would include an untrue statement of a material fact or omitted
or would omit to state a material fact required to be stated therein or
necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading.
- 3
-
(f) The
documents incorporated by reference in the Preliminary Prospectus, the
Prospectus and the Registration Statement, when they were filed with the
Commission conformed in all material respects to the requirements of the
Securities Act or the Exchange Act, as applicable, and the rules and regulations
of the Commission thereunder and none of such documents contained any untrue
statement of a material fact or omitted to state any material fact required to
be stated therein or necessary to make the statements therein not misleading;
and any further documents so filed and incorporated by reference in the
Prospectus, when such documents are filed with Commission will conform in all
material respects to the requirements of the Securities Act or the Exchange Act,
as applicable, and the rules and regulations of the Commission thereunder and
will not contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements
therein not misleading.
(g) The
Company has not, directly or indirectly, distributed and will not distribute any
offering material in connection with the offering and sale of the Shares other
than any Preliminary Prospectus, the Prospectus and other materials, if any,
permitted under the Securities Act and consistent with Section 4(b)
below. The Company will file with the Commission all Issuer Free
Writing Prospectuses in the time and manner required under Rules 163(b)(2) and
433(d) of the Rules and Regulations.
(h) At
the time of filing the Initial Registration Statement, any 462(b) Registration
Statement and any post-effective amendments thereto, and at the date hereof, the
Company was not, and the Company currently is not, an “ineligible issuer,” as
defined in Rule 405 of the Rules and Regulations.
(i) The
Company and each of its subsidiaries (as defined in Section 15), other than the
PRC Subsidiaries (as defined below), have been duly organized and are validly
existing as corporations or other legal entities in good standing (or the
foreign equivalent thereof) under the laws of their respective jurisdictions of
organization. The Company and each of its subsidiaries, other than
the PRC Subsidiaries, are duly qualified to do business and are in good standing
as foreign corporations or other legal entities in each jurisdiction in which
their respective ownership or lease of property or the conduct of their
respective businesses requires such qualification and have all power and
authority (corporate or other) necessary to own or hold their respective
properties and to conduct the businesses in which they are engaged, except where
the failure to so qualify or have such power or authority would not (i) have,
singularly or in the aggregate, a material adverse effect on the condition
(financial or otherwise), results of operations, assets, business or prospects
of the Company and its subsidiaries taken as a whole, or (ii) impair in any
material respect the ability of the Company to perform its obligations under
this Agreement or to consummate any transactions contemplated by this Agreement
in accordance with the terms of this Agreement, the General Disclosure Package
or the Prospectus (any such effect as described in clauses (i) or (ii), a
“Material Adverse Effect”). The Company owns or controls, directly or
indirectly, only the corporations, partnerships, limited liability partnerships,
limited liability companies, associations or other entities indicated on
Schedule C hereof.
(j) This
Agreement has been duly authorized, executed and delivered by the
Company.
(k) The
Shares to be issued and sold by the Company to the Underwriters hereunder has
been duly and validly authorized and, when issued and delivered against payment
therefor as provided herein, will be duly and validly issued, fully paid and
nonassessable and free of any preemptive or similar rights and will conform to
the description thereof contained in the General Disclosure Package and the
Prospectus.
(l) The
Company has an authorized capitalization as set forth under the heading
“Capitalization” in the Pricing Prospectus and the Prospectus, and all of the
issued shares of capital stock of the Company, have been duly and validly
authorized and issued, are fully paid and non-assessable, have been issued in
compliance with federal and state securities laws, and conform to the
description thereof contained in the General Disclosure Package and the
Prospectus. As of November 30, 2009, there were 38,351,198 shares of
Common Stock issued and outstanding and 1,455,000 shares of Common Stock were
issuable upon the exercise of all options, warrants and convertible securities
outstanding as of such date. Since such date, the Company has not issued any
securities other than Common Stock of the Company issued pursuant to the
exercise of stock options previously outstanding under the Company’s stock
option plans or the issuance of restricted Common Stock pursuant to employee
stock purchase plans. All of the Company’s options, warrants and
other rights to purchase or exchange any securities for shares of the Company’s
capital stock have been duly authorized and validly issued and were issued in
compliance with federal and state securities laws. None of the
outstanding shares of Common Stock was issued in violation of any preemptive
rights, rights of first refusal or other similar rights to subscribe for or
purchase securities of the Company. There are no authorized or
outstanding shares of capital stock, options, warrants, preemptive rights,
rights of first refusal or other rights to purchase, or equity or debt
securities convertible into or exchangeable or exercisable for, any capital
stock of the Company or any of its subsidiaries other than those described above
or accurately described in the General Disclosure Package. The
description of the Company’s stock option, stock bonus and other stock plans or
arrangements, and the options or other rights granted thereunder, as described
in the General Disclosure Package and the Prospectus, accurately and fairly
present the information required to be shown with respect to such plans,
arrangements, options and rights.
- 4
-
(m) All
the outstanding shares of capital stock (if any) of each subsidiary of the
Company have been duly authorized and validly issued, are fully paid and
nonassessable and, except to the extent set forth in the General Disclosure
Package or the Prospectus, are owned by the Company directly or indirectly
through one or more wholly-owned subsidiaries, free and clear of any claim,
lien, encumbrance, security interest, restriction upon voting or transfer or any
other claim of any third party.
(n) The
execution, delivery and performance of this Agreement by the Company, the issue
and sale of the Shares by the Company and the consummation of the transactions
contemplated hereby will not (with or without notice or lapse of time or both)
conflict with or result in a breach or violation of any of the terms or
provisions of, constitute a default or a Debt Repayment Triggering Event (as
defined below) under, give rise to any right of termination or other right or
the cancellation or acceleration of any right or obligation or loss of a benefit
under, or give rise to the creation or imposition of any lien, encumbrance,
security interest, claim or charge upon any property or assets of the Company or
any subsidiary pursuant to, any indenture, mortgage, deed of trust, loan
agreement or other agreement or instrument to which the Company or any of its
subsidiaries is a party or by which the Company or any of its subsidiaries is
bound or to which any of the property or assets of the Company or any of its
subsidiaries is subject, nor will such actions result in any violation of the
provisions of the charter or by-laws (or analogous governing instruments, as
applicable) of the Company or any of its subsidiaries or any law, statute, rule,
regulation, judgment, order or decree of any court or governmental agency or
body, domestic or foreign, having jurisdiction over the Company or any of its
subsidiaries or any of their properties or assets. A “Debt Repayment
Triggering Event” means any event or condition that gives, or with the giving of
notice or lapse of time would give the holder of any note, debenture or other
evidence of indebtedness (or any person acting on such holder’s behalf) the
right to require the repurchase, redemption or repayment of all or a portion of
such indebtedness by the Company of any of its subsidiaries.
(o) Except
for the registration of the Shares under the Securities Act and applicable state
securities laws, the Financial Industry Regulatory Authority (“FINRA”) and the
Nasdaq Global Market in connection with the purchase and distribution of the
Shares by the Underwriters and the listing of the Shares on the Nasdaq Global
Market, no consent, approval, authorization or order of, or filing,
qualification or registration (each an “Authorization”) with, any court,
governmental or non-governmental agency or body, foreign or domestic, which has
not been made, obtained or taken and is not in full force and effect, is
required for the execution, delivery and performance of this Agreement by the
Company, the offer or sale of the Shares by the Company or the consummation of
the transactions contemplated hereby; and to the Knowledge of the Company, no
event has occurred that allows or results in, or after notice or lapse of time
or both would allow or result in, revocation, suspension, termination or
invalidation of any such Authorization or any other impairment of the rights of
the holder or maker of any such Authorization. All corporate
approvals (including those of stockholders) necessary for the Company to
consummate the transactions contemplated by this Agreement have been obtained
and are in effect.
(p) To
the Company’s Knowledge, each of Deloitte Touche Tohmatsu CPA Ltd. and Xxxxx
X.X. Xxxxxx & Co., who have certified certain financial statements included
or incorporated by reference in the Registration Statements, the General
Disclosure Package and the Prospectus, and Deloitte Touche Tohmatsu CPA Ltd.,
who have audited the Company’s internal control over financial reporting and
management’s assessment thereof, is an independent registered public accounting
firm within the meaning of Article 2-01 of Regulation S-X and the Public Company
Accounting Oversight Board (United States) (the “PCAOB”).
- 5
-
(q) The
financial statements, together with the related notes, included or incorporated
by reference in the General Disclosure Package, the Prospectus and in each
Registration Statement fairly present the financial position and the results of
operations and changes in financial position of the Company and its consolidated
subsidiaries at the respective dates or for the respective periods therein
specified. Such statements and related notes have been prepared in
accordance with the generally accepted accounting principles in the United
States (“GAAP”) applied on a consistent basis throughout the periods involved
except as may be set forth in the related notes included in the General
Disclosure Package. The financial statements, together with the
related notes, included or incorporated by reference in the General Disclosure
Package and the Prospectus comply in all material respects with Regulation
S-X. No other financial statements or supporting schedules or
exhibits are required by Regulation S-X to be described, included or
incorporated by reference in the Registration Statements, the General Disclosure
Package or the Prospectus. There is no pro forma or as adjusted
financial information which is required to be included in the Registration
Statements, the General Disclosure Package, and the Prospectus or a document
incorporated by reference therein in accordance with Regulation S-X which has
not been included or incorporated as so required. The summary and
selected financial data included or incorporated by reference in the General
Disclosure Package, the Prospectus and each Registration Statement fairly
present the information shown therein as at the respective dates and for the
respective periods specified and are derived from the consolidated financial
statements set forth incorporated by reference in the Registration Statement,
the Pricing Prospectus and the Prospectus and other financial
information. All information contained in the Registration
Statements, the General Disclosure Package and the Prospectus regarding
“non-GAAP financial measures” (as defined in Regulation G) complies with
Regulation G and Item 10 of Regulations S-K, to the extent
applicable.
(r) Neither
the Company nor any of its subsidiaries has sustained, since the date of the
latest audited financial statements included or incorporated by reference in the
General Disclosure Package, any material loss or interference with its business
from fire, explosion, flood or other calamity, whether or not covered by
insurance, or from any labor dispute or court or governmental action, order or
decree, otherwise than as set forth or contemplated in the General Disclosure
Package; and, since such date, there has not been any change in the capital
stock or long-term debt of the Company or any of its subsidiaries, or any
material adverse changes, or any development involving a prospective material
adverse change, in or affecting the business, assets, general affairs,
management, financial position, prospects, stockholders’ equity or results of
operations of the Company and its subsidiaries taken as a whole, otherwise than
as set forth or contemplated in the General Disclosure Package.
(s) Except
as set forth in the General Disclosure Package and the Prospectus, there is no
legal or governmental proceeding pending to which the Company or any of its
subsidiaries is a party or of which any property or assets of the Company or any
of its subsidiaries is the subject which is required to be described in the
Registration Statements, the General Disclosure Package or the Prospectus or a
document incorporated by reference therein and is not described therein, or
which, singularly or in the aggregate, if determined adversely to the Company or
any of its subsidiaries, could reasonably be expected to have a Material Adverse
Effect; and to the best of the Company’s knowledge after reasonable
investigation and due diligence inquiry (“Knowledge”), no such proceedings are
threatened or contemplated by governmental authorities or threatened by
others.
(t) Neither
the Company nor any of its subsidiaries (i) is in violation of its certificate
of incorporation or by-laws (or analogous governing instrument, as applicable),
(ii) is in default in any respect, and no event has occurred which, with notice
or lapse of time or both, would constitute such a default, in the due
performance or observance of any term, covenant or condition contained in any
indenture, mortgage, deed of trust, loan agreement, lease or other agreement or
instrument to which it is a party or by which it is bound or to which any of its
property or assets is subject or (iii) is in violation in any respect of any
law, ordinance, governmental rule, regulation or court order, decree or judgment
to which it or its property or assets may be subject except, in the case of
clauses (ii) and (iii) of this paragraph (t), for any violations or defaults
which, singularly or in the aggregate, would not have a Material Adverse
Effect.
- 6
-
(u) The
Company and each of its subsidiaries possess all licenses, certificates,
authorizations and permits issued by, and have made all declarations and filings
with, the appropriate local, state, federal or foreign regulatory agencies or
bodies which are necessary or desirable for the ownership of their respective
properties or the conduct of their respective businesses as described in the
General Disclosure Package and the Prospectus (collectively, the “Governmental
Permits”) except where any failures to possess or make the same, singularly or
in the aggregate, would not have a Material Adverse Effect. The
Company and its subsidiaries are in compliance with all such Governmental
Permits; all such Governmental Permits are valid and in full force and effect,
except where the validity or failure to be in full force and effect would not,
singularly or in the aggregate, have a Material Adverse Effect. To
the Knowledge of the Company, all such Governmental Permits are free and clear
of any restriction or condition that are in addition to, or materially different
from those normally applicable to similar licenses, certificates, authorizations
and permits. Neither the Company nor any subsidiary has received notification of
any revocation, modification, suspension, termination or invalidation (or
proceedings related thereto) of any such Governmental Permit and to the
Knowledge of the Company, no event has occurred that allows or results in, or
after notice or lapse of time or both would allow or result in, revocation,
modification, suspension, termination or invalidation (or proceedings related
thereto ) of any such Governmental Permit and the Company has no reason to
believe that any such Governmental Permit will not be renewed.
(v) Neither
the Company nor any of its subsidiaries is or, after giving effect to the
offering of the Shares and the application of the proceeds thereof as described
in the General Disclosure Package and the Prospectus, will become an “investment
company” within the meaning of the Investment Company Act of 1940, as amended,
and the rules and regulations of the Commission thereunder.
(w) Neither
the Company nor any of its officers, directors or affiliates has taken or will
take, directly or indirectly, any action designed or intended to stabilize or
manipulate the price of any security of the Company, or which caused or resulted
in, or which might in the future reasonably be expected to cause or result in,
stabilization or manipulation of the price of any security of the
Company.
(x) The
Company and its subsidiaries own or possess the valid right to use all (i) valid
and enforceable patents, patent applications, trademarks, trademark
registrations, service marks, service xxxx registrations, Internet domain name
registrations, copyrights, copyright registrations, licenses and trade secret
rights (“Intellectual Property Rights”) and (ii) inventions, software, works of
authorships, trade marks, service marks, trade names, databases, formulae, know
how, Internet domain names and other intellectual property (including trade
secrets and other unpatented and/or unpatentable proprietary confidential
information, systems, or procedures) (collectively, “Intellectual Property
Assets”), in each case as necessary to conduct their respective businesses as
currently conducted, and as proposed to be conducted and described in the
General Disclosure Package and the Prospectus. The Company and its
subsidiaries have not received any opinion from their legal counsel concluding
that any activities of their respective businesses infringe, misappropriate, or
otherwise violate, valid and enforceable Intellectual Property Rights of any
other person, and have not received written notice of any challenge, which is to
their Knowledge still pending, by any other person to the rights of the Company
and its subsidiaries with respect to any Intellectual Property Rights or
Intellectual Property Assets owned or used by the Company or its
subsidiaries. To the Knowledge of the Company, the Company and its
subsidiaries’ respective businesses as now conducted do not give rise to any
infringement of, any misappropriation of, or other violation of, any valid and
enforceable Intellectual Property Rights of any other person. To the
Knowledge of the Company, all licenses for the use of the Intellectual Property
Rights described in the General Disclosure Package and the Prospectus are valid,
binding upon, and enforceable by or against the parties thereto in accordance to
its terms. The Company has complied in all material respects with,
and is not in breach nor has received any asserted or threatened claim of breach
of any Intellectual Property license, and the Company has no knowledge of any
breach or anticipated breach by any other person to any Intellectual Property
license. Except as described in the General Disclosure Package, no
claim has been made against the Company alleging the infringement by the Company
of any patent, trademark, service xxxx, trade name, copyright, trade secret,
license in or other intellectual property right or franchise right of any
person. The Company has taken all reasonable steps to protect,
maintain and safeguard its Intellectual Property Rights, including the execution
of appropriate nondisclosure and confidentiality agreements. The
consummation of the transactions contemplated by this Agreement will not result
in the loss or impairment of or payment of any additional amounts with respect
to, nor require the consent of any other person in respect of, the Company’s
right to own, use, or hold for use any of the Intellectual Property Rights as
owned, used or held for use in the conduct of the business as currently
conducted. With respect to the use of the software in the Company’s
business as it is currently conducted, the Company has not experienced any
material defects in such software including any material error or omission in
the processing of any transactions other than defects which have been corrected,
and to the knowledge of the Company, no such software contains any device or
feature designed to disrupt, disable, or otherwise impair the functioning of any
software or is subject to the terms of any “open source” or other similar
license that provides for the source code of the software to be publicly
distributed or dedicated to the public. The Company has at all times
complied with all applicable laws relating to privacy, data protection, and the
collection and use of personal information collected, used, or held for use by
the Company in the conduct of the Company’s business, except where the failure
to comply would not have a Material Adverse Effect. No claims have
been asserted or, to the Company’s Knowledge, threatened against the Company
alleging a violation of any person’s privacy or personal information or data
rights and the consummation of the transactions contemplated hereby will not
breach or otherwise cause any violation of any law related to privacy, data
protection, or the collection and use of personal information collected, used,
or held for use by the Company in the conduct of the Company’s
business. The Company has taken reasonable measures to ensure that
such information is protected against unauthorized access, use, modification, or
other misuse. The Company has taken all necessary actions to obtain
ownership of all works of authorship and inventions made by its employees,
consultants and contractors during the time they were employed by or under
contract with the Company and which relate to the Company’s
business.
- 7
-
(y) Except
as described in the General Disclosure Package and the Prospectus, the Company
and each of its subsidiaries have good and, subject to applicable PRC law,
marketable title to, or have valid rights to lease or otherwise use, all items
of real or personal property which are material to the business of the Company
and its subsidiaries taken as a whole, in each case free and clear of all liens,
encumbrances, security interests, claims and defects that do not, singularly or
in the aggregate, materially affect the value of such property and do not
interfere with the use made and proposed to be made of such property by the
Company or any of its subsidiaries; and all of the leases and subleases material
to the business of the Company and its subsidiaries, considered as one
enterprise, and under which the Company or any of its subsidiaries holds
properties described in the General Disclosure Package and the Prospectus, are
in full force and effect, and neither the Company nor any subsidiary has any
notice of any material claim of any sort that has been asserted by anyone
adverse to the rights of the Company or any subsidiary under any of the leases
or subleases mentioned above, or affecting or questioning the rights of the
Company or such subsidiary to the continued possession of the leased or
subleased premises under any such lease or sublease.
(z) There
is (A) no significant unfair labor practice complaint pending against the
Company, or any of its subsidiaries, nor to the Knowledge of the Company,
threatened against it or any of its subsidiaries, before the National Labor
Relations Board, any state or local labor relation board or any foreign labor
relations board, and no significant grievance or significant arbitration
proceeding arising out of or under any collective bargaining agreement is so
pending against the Company or any of its subsidiaries, or, to the Knowledge of
the Company, threatened against it and (B) no labor disturbance by the employees
of the Company or any of its subsidiaries exists or, to the Company’s Knowledge,
is imminent, and the Company is not aware of any existing or imminent labor
disturbance by the employees of any of its or its subsidiaries principal
suppliers, manufacturers, customers or contractors, that could reasonably be
expected, singularly or in the aggregate, to have a Material Adverse
Effect. The Company is not aware that any key employee or significant
group of employees of the Company or any subsidiary plans to terminate
employment with the Company or any such subsidiary.
(aa) No
“prohibited transaction” (as defined in Section 406 of the Employee Retirement
Income Security Act of 1974, as amended, including the regulations and published
interpretations thereunder (“ERISA”), or Section 4975 of the Internal Revenue
Code of 1986, as amended from time to time (the “Code”)) or “accumulated funding
deficiency” (as defined in Section 302 of ERISA) or any of the events set forth
in Section 4043(b) of ERISA (other than events with respect to which the thirty
(30)-day notice requirement under Section 4043 of ERISA has been waived) has
occurred or could reasonably be expected to occur with respect to any employee
benefit plan of the Company or any of its subsidiaries which could, singularly
or in the aggregate, have a Material Adverse Effect. Each employee
benefit plan of the Company or any of its subsidiaries is in compliance in all
material respects with applicable law, including ERISA and the Code. The Company
and its subsidiaries have not incurred and could not reasonably be expected to
incur liability under Title IV of ERISA with respect to the termination of, or
withdrawal from, any pension plan (as defined in ERISA). Each pension
plan for which the Company or any of its subsidiaries would have any liability
that is intended to be qualified under Section 401(a) of the Code is so
qualified, and nothing has occurred, whether by action or by failure to act,
which could, singularly or in the aggregate, cause the loss of such
qualification.
- 8
-
(bb) The
Company and its subsidiaries are in compliance with all foreign, federal, state
and local rules, laws and regulations relating to the use, treatment, storage
and disposal of hazardous or toxic substances or waste and protection of health
and safety or the environment which are applicable to their businesses
(“Environmental Laws”), except where the failure to comply would not have a
Material Adverse Effect. To the Knowledge of the Company, there has
been no storage, generation, transportation, handling, treatment, disposal,
discharge, emission, or other release of any kind of toxic or other wastes or
other hazardous substances by, due to, or caused by the Company or any of its
subsidiaries (or, to the Company’s Knowledge, any other entity for whose acts or
omissions the Company or any of its subsidiaries is or may otherwise be liable)
upon any of the property now or previously owned or leased by the Company or any
of its subsidiaries, or upon any other property, in violation of any law,
statute, ordinance, rule, regulation, order, judgment, decree or permit or which
would, under any law, statute, ordinance, rule (including rule of common law),
regulation, order, judgment, decree or permit, give rise to any liability; and
there has been no disposal, discharge, emission or other release of any kind
onto such property or into the environment surrounding such property of any
toxic or other wastes or other hazardous substances with respect to which the
Company or any of its subsidiaries has knowledge. In the ordinary
course of business, the Company and its subsidiaries conduct periodic reviews of
the effect of Environmental Laws on their business and assets, in the course of
which they identify and evaluate associated costs and liabilities (including,
without limitation, any capital or operating expenditures required for clean-up,
closure of properties or compliance with Environmental Laws or Governmental
Permits issued thereunder, any related constraints on operating activities and
any potential liabilities to third parties). On the basis of such
reviews, the Company has reasonably concluded that such associated costs and
liabilities would not have, singularly or in the aggregate, a Material Adverse
Effect.
(cc) The
Company and its subsidiaries each (i) have timely filed all necessary federal,
state, local and foreign tax returns, and all such returns were true, complete
and correct, (ii) have paid all federal, state, local and foreign taxes,
assessments, governmental or other charges due and payable for which it is
liable, including, without limitation, all sales and use taxes and all taxes
which the Company or any of its subsidiaries is obligated to withhold from
amounts owing to employees, creditors and third parties, and (iii) do not have
any tax deficiency or claims outstanding or assessed or, to its Knowledge,
proposed against any of them, except those, in each of the cases described in
clauses (i), (ii) and (iii) of this paragraph (cc), that would not, singularly
or in the aggregate, have a Material Adverse Effect. To the Company’s
Knowledge, the Company and its subsidiaries have not engaged in any transaction
which is a corporate tax shelter or which could be characterized as such by the
Internal Revenue Service or any other taxing authority. The accruals
and reserves on the books and records of the Company and its subsidiaries in
respect of tax liabilities for any taxable period not yet finally determined are
adequate to meet any assessments and related liabilities for any such period,
and since December 31, 2008 the Company and its subsidiaries have not incurred
any liability for taxes other than in the ordinary course.
(dd) The
Company and each of its subsidiaries carry, or are covered by, insurance in such
amounts and covering such risks as is adequate for the conduct of their
respective businesses and the value of their respective properties and as is
customary for companies engaged in similar businesses in similar
industries. Neither the Company nor any of its subsidiaries has any
reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from
similar insurers as may be necessary to continue its business at a cost that
would not have a Material Adverse Effect. All policies of insurance
owned by the Company or any of its subsidiaries are, to the Company’s Knowledge,
in full force and effect and the Company and its subsidiaries are in compliance
with the terms of such policies. Neither the Company nor any of its
subsidiaries has received written notice from any insurer, agent of such insurer
or the broker of the Company or any of its subsidiaries that any material
capital improvements or any other material expenditures (other than premium
payments) are required or necessary to be made in order to continue such
insurance. None of the Company or any of its subsidiaries insures
risk of loss through any captive insurance, risk retention group, reciprocal
group or by means of any fund or pool of assets specifically set aside for
contingent liabilities other than as described in the General Disclosure
Package.
- 9
-
(ee) The
Company and each of its subsidiaries maintains a system of internal control over
financial reporting (as such term is defined in Rule 13a-15 of the General Rules
and Regulations under the Exchange Act (the “Exchange Act Rules”))
that complies with the requirements of the Exchange Act and has been designed by
the Company’s principal executive officer and principal financial officer, or
under their supervision, to provide reasonable assurances that (i) transactions
are executed in accordance with management’s general or specific authorizations;
(ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain accountability for assets;
(iii) access to assets is permitted only in accordance with management’s general
or specific authorization; and (iv) the recorded accountability for assets is
compared with existing assets at reasonable intervals and appropriate action is
taken with respect to any differences. The Company’s internal control
over financial reporting is effective. Except as described in the
General Disclosure Package, since the end of the Company’s most recent audited
fiscal year, there has been (A) no material weakness in the Company’s internal
control over financial reporting (whether or not remediated) and (B) no change
in the Company’s internal control over financial reporting that has materially
affected, or is reasonably likely to materially affect, the Company’s internal
control over financial reporting. The Company’s internal control over
financial reporting is, or upon consummation of the offering of the Shares will
be, overseen by the Audit Committee of the Board of Directors of the Company
(the “Audit Committee”) in accordance with the Exchange Act
Rules. The Company has not publicly disclosed or reported to the
Audit Committee or to the Board, and within the next 90 days the Company does
not reasonably expect to publicly disclose or report to the Audit Committee or
the Board, a significant deficiency, material weakness, change in internal
control over financial reporting or fraud involving management or other
employees who have a significant role in the internal control over financial
reporting (each an “Internal Control Event”), any violation of, or failure to
comply with, the Securities Act, the Exchange Act or any of the rules and
regulations promulgated thereunder, or any matter which if determined adversely,
would have a Material Adverse Effect.
(ff) A
member of the Audit Committee has confirmed to the Chief Executive Officer,
Chief Financial Officer or General Counsel that, except as set forth in the
General Disclosure Package, the Audit Committee is not reviewing or
investigating, and neither the Company’s independent auditors nor its internal
auditors have recommended that the Audit Committee review or investigate, (i)
adding to, deleting, changing the application of or changing the
Company’s disclosure with respect to, any of the Company’s material accounting
policies, (ii) any matter which could result in a restatement of the Company’s
financial statements for any annual or interim period during the current or
prior three fiscal years, or (iii) any Internal Control Event.
(gg) The
Company and each of its subsidiaries have made and keep books, records and
accounts, which, in reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of the Company and its subsidiaries
in all material respects.
(hh) The
Company maintains disclosure controls and procedures (as such is defined in Rule
13a-15 of the Exchange Act Rules) that comply with the requirements of the
Exchange Act; such disclosure controls and procedures have been designed to
ensure that information required to be disclosed by the Company and its
subsidiaries is accumulated and communicated to the Company’s management,
including the Company’s principal executive officer and principal financial
officer by others within those entities, such disclosure controls and procedures
are effective.
(ii) The
minute books of the Company and each of its subsidiaries that would be a
“significant subsidiary” within the meaning of Rule 1-02(w) of Regulation
S-X (such a significant subsidiary of the Company, a “Significant
Subsidiary”) have been made available to the Underwriters and counsel for the
Underwriters, and such books (i) contain a complete summary of all meetings and
actions of the board of directors (including each board committee) and
shareholders of the Company (or analogous governing bodies and interest holders,
as applicable), and each of its Significant Subsidiaries since the time of its
respective incorporation or organization through the date of the latest meeting
and action, and (ii) accurately in all material respects reflect all
transactions referred to in such minutes.
- 10
-
(jj) There
is no franchise agreement, lease, contract, or other agreement or document
required by the Securities Act or by the Rules and Regulations to be described
in the General Disclosure Package and in the Prospectus or a document
incorporated by reference therein or to be filed as an exhibit to the
Registration Statements or a document incorporated by reference therein which is
not so described or filed therein as required; and all descriptions of any such
franchise agreements, leases, contracts, or other agreements or documents
contained in the General Disclosure Package and in the Prospectus or in a
document incorporated by reference therein are accurate and complete
descriptions of such documents in all material respects. Other than
as described in the General Disclosure Package, no such franchise agreement,
lease, contract or other agreement has been suspended or terminated for
convenience or default by the Company or any of the other parties thereto, and
neither the Company nor any of its subsidiaries has received notice of and the
Company does not have Knowledge of any such pending or threatened suspension or
termination.
(kk) No
relationship, direct or indirect, exists between or among the Company on the one
hand, and the directors, officers, stockholders (or analogous interest holders),
customers or suppliers of the Company or any of its affiliates on the other
hand, which is required to be described in the General Disclosure Package and
the Prospectus or a document incorporated by reference therein and which is not
so described.
(ll) No
person or entity has the right to require registration of shares of Common Stock
or other securities of the Company or any of its subsidiaries because of the
filing or effectiveness of the Registration Statements, except for persons and
entities who have expressly waived such right in writing or who have been given
timely and proper written notice and have failed to exercise such right within
the time or times required under the terms and conditions of such
right. Except as described in the General Disclosure Package, there
are no persons with registration rights or similar rights to have any securities
registered by the Company or any of its subsidiaries under the Securities
Act.
(mm) Neither
the Company nor any of its subsidiaries own any “margin securities” as that term
is defined in Regulation U of the Board of Governors of the Federal Reserve
System (the “Federal Reserve Board”), and none of the proceeds of the sale of
the Shares will be used, directly or indirectly, for the purpose of purchasing
or carrying any margin security, for the purpose of reducing or retiring any
indebtedness which was originally incurred to purchase or carry any margin
security or for any other purpose which might cause any of the Shares to be
considered a “purpose credit” within the meanings of Regulation T, U or X of the
Federal Reserve Board.
(nn) Neither
the Company nor any of its subsidiaries is a party to any contract, agreement or
understanding with any person that would give rise to a valid claim against the
Company or the Underwriters for a brokerage commission, finder’s fee or like
payment in connection with the offering and sale of the Shares or any
transaction contemplated by this Agreement, the Registration Statements, the
General Disclosure Package or the Prospectus.
(oo) The
exercise price of each option issued under the Company’s stock option or other
employee benefit plans has been no less than the fair market value of a share of
common stock as determined on the date of grant of such option. All
grants of options were validly issued and properly approved by the board of
directors of the Company (or a duly authorized committee thereof) in material
compliance with all applicable laws and regulations and recorded in the
Company’s financial statements in accordance with GAAP and, to the Company’s
Knowledge, no such grants involved “back dating,” “forward dating” or similar
practice with respect to the effective date of grant.
(pp) Except
as described in the General Disclosure Package and the Prospectus, no subsidiary
of the Company is currently prohibited, directly or indirectly, under any
agreement or other instrument to which it is a party or is subject, from paying
any dividends to the Company, from making any other distribution on such
subsidiary’s capital stock, from repaying to the Company any loans or advances
to such subsidiary from the Company or from transferring any of such
subsidiary’s properties or assets to the Company or any other subsidiary of the
Company.
- 11
-
(qq) Since
the date as of which information is given in the General Disclosure Package and
the Prospectus through the date hereof, and except as set forth in the Pricing
Prospectus and the Prospectus, neither the Company nor any of its subsidiaries
has (i) issued or granted any securities other than options to purchase common
stock pursuant to the Company’s stock option plan, (ii) incurred any material
liability or obligation, direct or contingent, other than liabilities and
obligations which were incurred in the ordinary course of business, (iii)
entered into any material transaction other than in the ordinary course of
business or (iv) declared or paid any dividend on its capital
stock.
(rr) If
applicable, all of the information provided to the Underwriters or to counsel
for the Underwriters by the Company, its officers and directors and the holders
of any securities (debt or equity) or options to acquire any securities of the
Company in connection with letters, filings or other supplemental information
provided to FINRA pursuant to NASD Conduct rule 2710 or 2720 is true, correct
and complete.
(ss) The
Company is not a Passive Foreign Investment Company (“PFIC”) within the meaning
of Section 1296 of the United States Internal Revenue Code of 1966, and the
Company is not likely to become a PFIC.
(tt) No
forward-looking statement (within the meaning of Section 27A of the Securities
Act and Section 21E of the Exchange Act) contained in either the General
Disclosure Package or the Prospectus has been made or reaffirmed without a
reasonable basis or has been disclosed other than in good faith.
(uu) The
Company is subject to and in compliance in all material respects with the
reporting requirements of Section 13 or Section 15(d) of the Exchange
Act. The Common Stock is registered pursuant to Section 12(b) or
12(g) of the Exchange Act and is listed on the Nasdaq Global Market (the “Exchange”), and
the Company has taken no action designed to, or reasonably likely to have the
effect of, terminating the registration of the Common Stock under the Exchange
Act or delisting the Common Stock from the Exchange, nor has the Company
received any notification that the Commission or FINRA is contemplating
terminating such registration or listing. No consent, approval,
authorization or order of, or filing, notification or registration with, the
Exchange is required for the listing and trading of the Shares on the Exchange,
except for those which shall have been made or obtained prior to the Closing
Date.
(vv) The
Company is in compliance in all material respects with all applicable provisions
of the Xxxxxxxx-Xxxxx Act of 2002 and all rules and regulations promulgated
thereunder or implementing the provisions thereof (the “Xxxxxxxx-Xxxxx Act”)
that are then in effect and is actively taking steps to ensure that it will be
in compliance with other applicable provisions of the Xxxxxxxx-Xxxxx Act not
currently in effect upon it and at all times after the applicability of such
provisions to the Company.
(ww) The
Company is in compliance in all material respects with all applicable corporate
governance requirements set forth in the rules of the Exchange that
are then in effect and is actively taking steps to ensure that it will be in
compliance with other applicable corporate governance requirements set forth in
the rules of the Exchange not currently applicable to the Company and all times
after the applicability of such requirements to the Company.
(xx) Neither
the Company nor any of its subsidiaries nor, to the Company’s
Knowledge, any employee or agent of the Company or any subsidiary, has (i) used
any corporate funds for unlawful contributions, gifts, entertainment or other
unlawful expenses relating to political activity, (ii) made any unlawful payment
to foreign or domestic government officials or employees or to foreign or
domestic political parties or campaigns from corporate funds, (iii) violated any
provision of the Foreign Corrupt Practices Act of 1977, as amended or (iv) made
any other unlawful payment.
(yy) There
are no transactions, arrangements or other relationships between and/or among
the Company, any of its affiliates (as such term is defined in Rule 405 of the
Rules and Regulations) and any unconsolidated entity, including, but not limited
to, any structured finance, special purpose or limited purpose entity that could
reasonably be expected to materially affect the Company’s liquidity or the
availability of or requirements for its capital resources required to be
described in the General Disclosure Package and the Prospectus or a document
incorporated by reference therein which have not been described as
required.
- 12
-
(zz) There
are no outstanding loans, advances (except normal advances for business expenses
in the ordinary course of business) or guarantees of indebtedness by the Company
or any of its subsidiaries to or for the benefit of any of the officers or
directors of the Company, any of its subsidiaries or any of their respective
family members, except as disclosed in the Registration Statements, the General
Disclosure Package and the Prospectus. All transactions by the
Company with office holders or control persons of the Company have been duly
approved by the board of directors of the Company, or duly appointed committees
or officers thereof, if and to the extent required under U.S. law.
(aaa) The
statistical and market related data included in the Registration Statement, the
General Disclosure Package and the Prospectus are based on or derived from
sources that the Company believes to be reliable and accurate, and such data
agree with the sources from which they are derived.
(bbb) The
operations of the Company and its subsidiaries are and have been conducted at
all times in compliance with applicable financial recordkeeping and reporting
requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, applicable money laundering statutes and applicable rules and
regulations thereunder (collectively, the “Money Laundering Laws”), and no
action, suit or proceeding by or before any court or governmental agency,
authority or body or any arbitrator involving the Company or any of its
subsidiaries with respect to the Money Laundering Laws is pending, or to the
Company’s Knowledge, threatened.
(ccc) Neither
the Company nor any of its subsidiaries nor, to the Company’s Knowledge, any
director, officer, agent, employee or affiliate of the Company or any of its
subsidiaries is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and
the Company will not directly or indirectly use the proceeds of the offering, or
lend, contribute or otherwise make available such proceeds to any subsidiary,
joint venture partner or other person or entity, for the purpose of financing
the activities of any person currently subject to any U.S. sanctions
administered by OFAC.
(ddd) Neither
the Company nor any of its affiliates (within the meaning of NASD Conduct Rule
2720(b)(1)(a)) directly or indirectly controls, is controlled by, or is under
common control with, or is an associated person (within the meaning of Article
I, Section 1(ee) of the By-laws of FINRA) of, any member firm of
FINRA.
(II) Representations
as to PRC Matters.
(a) The
Company conducts substantially all of its operations and generates substantially
all of its revenue through (1) the wholly foreign-owned enterprises formed
under the laws of the People’s Republic of China (the “PRC”) indicated as PRC
Subsidiaries on Schedule C hereof (collectively, the “PRC Subsidiaries”),
and (2) the companies formed under the laws of the PRC indicated as PRC
VIEs on Schedule C hereof (the “PRC VIEs”). The PRC Subsidiaries
and the PRC VIEs are collectively referred to hereinafter as the “PRC
Entities.”
(b) Each
of the PRC Entities has been duly established, is validly existing as a company
in good standing under the laws of the PRC, has the corporate power and
authority to own, lease and operate its property and to conduct its business as
described in the Registration Statement, the Time of Sale Disclosure Package and
the Prospectus, and is duly qualified to transact business and is in good
standing in each jurisdiction in which the conduct of its business or its
ownership or leasing of property requires such qualification, except to the
extent that the failure to be so qualified or be in good standing would not,
singly or in the aggregate, have a Material Adverse Effect. Each PRC
Entity has applied for and obtained all requisite business licenses, clearance
and permits required under PRC law as necessary for the conduct of its
businesses, and each PRC Entity has complied in all material respects
with all PRC Laws in connection with foreign exchange, including without
limitation, carrying out all relevant filings, registrations and applications
for relevant permits with the PRC State Administration of Foreign Exchange and
any other relevant authorities, and all such permits are validly
subsisting. Except as disclosed in the Registration Statement, the
General Disclosure Package and the Prospectus, the registered capital of each
PRC Entity has been fully paid up in accordance with the schedule of payment
stipulated in its respective articles of association, approval document,
certificate of approval and legal person business license (hereinafter referred
to as the “Establishment Documents”) and in compliance with PRC laws and
regulations, and there is no outstanding capital contribution commitment for any
PRC Entity. The Establishment Documents of the PRC Entities have been
duly approved in accordance with the laws of the PRC and are valid and
enforceable. The business scope specified in the Establishment
Documents of each PRC Entity complies with the requirements of all relevant PRC
laws and regulations. The outstanding equity interests of each PRC
Entity is owned of record by the respective entities or individuals identified
as the registered holders thereof in the Registration Statement, the General
Disclosure Package and the Prospectus.
- 13
-
(c) Except
as disclosed in the Registration Statement, the General Disclosure Package and
the Prospectus, no consents, approvals, authorizations, orders, registrations,
clearances, certificates, franchises, licenses, permits or qualifications of or
with any PRC governmental agency are required for the Company’s or its
subsidiaries’ contractual arrangements and agreements with the PRC VIEs and
their registered equity holders (the “VIE Structure”) or the execution, delivery
and performance of such contractual arrangements and agreements (the “VIE
Structuring Documents”). None of the VIE Structuring Documents has
been revoked and no such revocation is pending or threatened. Each of
the VIE Structuring Documents has been entered into prior to the date thereof in
compliance with all applicable laws and regulations and constitutes a valid and
legally binding agreement, enforceable in accordance with its
terms.
(d) The
VIE Structure and the execution, delivery and performance of the VIE Structuring
Documents and the consummation of the transactions contemplated thereby did not
and do not (i) conflict with, or result in a breach or violation of any of
the terms and provisions of, or constitute a default under, any indenture,
mortgage, deed of trust, loan agreement or other agreement or instrument to
which any PRC Entity is a party or by which any PRC Entity is bound or by which
any of the properties or assets of any PRC Entity is subject, (ii) violate
or conflict with the Establishment Documents of any PRC Entity, or
(iii) violate or conflict with any mandatory provisions of applicable laws,
regulations, rules, orders, decrees, guidelines, notices or other legislation of
the PRC.
(e) The
VIE Structure complies, and after the consummation of the offering and sale of
the Shares will comply, with all applicable laws, regulations, rules, orders,
decrees, guidelines, notices or other legislation of the PRC; the VIE Structure
has not been challenged by any PRC governmental agency prior to the date of this
Agreement and there are no legal, arbitration, governmental or other proceedings
(including, without limitation, governmental investigations or inquiries)
pending before or, to the Company’s knowledge, threatened or contemplated by any
PRC governmental agency in respect of the VIE Structure; and the Company
reasonably believes that after the consummation of the offering and sale of the
Shares, the VIE Structure will not be challenged by any PRC governmental
agency.
(f) The
Company possesses, directly or indirectly, the power to direct, or cause the
direction of, the management and policies of the PRC VIEs.
(g) No
PRC Subsidiary is currently prohibited, directly or indirectly, from paying any
dividends to the Company (or the Company’s subsidiary that holds the outstanding
equity interest of such PRC Subsidiary), and no PRC VIE is currently prohibited,
directly or indirectly, from paying any of its obligations set forth in the VIE
Structuring Documents. No PRC Entity is prohibited, directly or
indirectly, from making any other distribution on such PRC Entity’s equity
capital, from repaying to the Company any loans or advances to such PRC Entity
from the Company or any of the Company’s subsidiaries.
(h) The
choice of the laws of the State of New York as the governing law of this
Agreement is a valid choice of law under the laws of the PRC and will be honored
by courts in the PRC.
(i) None
of the PRC Entities nor any of their properties, assets or revenues are entitled
to any right of immunity on the grounds of sovereignty from any legal action,
suit or proceeding, from set-off or counterclaim, from the jurisdiction of any
court, from services of process, from attachment prior to or in aid of execution
of judgment, or from any other legal process or proceeding for the giving of any
relief or for the enforcement of any judgment.
- 14
-
(j) It
is not necessary that this Agreement, the Registration Statements, the General
Disclosure Package, the Prospectus or any other document be filed or recorded
with any governmental agency, court or other authority in the PRC.
(k) No
transaction, stamp, capital or other issuance, registration, transaction,
transfer or withholding taxes or duties are payable in the PRC by or on behalf
of the Underwriters to any PRC taxing authority in connection with (i) the
issuance, sale and delivery of the Shares by the Company and the delivery of the
Shares to or for the account of the Underwriters, (ii) the purchase from
the Company and the initial sale and delivery by the Underwriters of the Shares
to purchasers thereof, or (iii) the execution and delivery of this
Agreement.
(l) The
Company has taken all necessary steps to comply with, and to ensure compliance
by all of the Company’s direct or indirect shareholders and option holders who
are PRC residents with, any applicable rules and regulations of the PRC State
Administration of Foreign Exchange of the PRC (the “SAFE Rules and
Regulations”), including, without limitation, requiring each shareholder and
option holder that is, or is directly or indirectly owned or controlled by, a
PRC resident to complete any registration and other procedures required under
applicable SAFE Rules and Regulations.
(m) The
Company is aware of, and has been advised as to, the content of the Rules on
Mergers and Acquisitions of Domestic Enterprises by Foreign Investors jointly
promulgated on August 8, 2006 by the PRC Ministry of Commerce, the PRC State
Assets Supervision and Administration Commission, the PRC State Administration
of Taxation, the PRC State Administration of Industry and Commerce, the China
Securities Regulatory Commission (“CSRC”) and the PRC State Administration of
Foreign Exchange of the PRC and amended Rules on Mergers and Acquisitions of
Domestic Enterprises by Foreign Investors promulgated on June 22, 2009 by the
PRC Ministry of Commerce (the “M&A Rules”), in particular the relevant
provisions thereof that purport to require offshore special purpose vehicles
controlled directly or indirectly by PRC-incorporated companies or PRC residents
and established for the purpose of obtaining a stock exchange listing outside of
the PRC to obtain the approval of the CSRC prior to the listing and trading of
their securities on any stock exchange located outside of the
PRC. The Company has received legal advice specifically with respect
to the M&A Rules from its PRC counsel and the Company understands such legal
advice. In addition, the Company has communicated such legal advice
in full to each of its directors that signed the Registration Statements and
each such director has confirmed that he or she understands such legal
advice.
(n) The
issuance and sale of the Shares, the listing and trading of the Shares on the
Exchange and the consummation of the transactions contemplated by this
Agreement, the Registration Statements, the General Disclosure Package and the
Prospectus are not and will not be, as of the date hereof and on each Closing
Date, prohibited or otherwise affected by the M&A Rules or any official
clarifications, guidance, interpretations or implementation rules in connection
with or related to the M&A Rules, including the guidance and notices issued
by the CSRC on September 8 and September 21, 2006 (together with the M&A
Rules, the “M&A Rules and Related Clarifications”).
(o) The
Company has taken all necessary steps to ensure compliance by each of its
shareholders, option holders, directors, officers and employees that is, or is
directly or indirectly owned or controlled by, a PRC resident or citizen with
any applicable rules and regulations of the relevant PRC government agencies
(including but not limited to the PRC Ministry of Commerce, the PRC National
Development and Reform Commission and the PRC State Administration of Foreign
Exchange) relating to overseas investment by PRC residents and citizens (the
“PRC Overseas Investment and Listing Regulations”), including, requesting each
shareholder, option holder, director, officer, employee and participant that is,
or is directly or indirectly owned or controlled by, a PRC resident or citizen
to complete any registration and other procedures required under applicable PRC
Overseas Investment and Listing Regulations.
- 15
-
(p) As
of the date hereof, the M&A Rules and Related Clarifications do not require
the Company to obtain the approval of the CSRC prior to the issuance and sale of
the Shares, the listing and trading of the Shares on the Exchange, or the
consummation of the transactions contemplated by this Agreement, the
Registration Statement, the General Disclosure Package or the
Prospectus.
(q) Each
of the PRC Entities is in compliance with all requirements under all applicable
PRC laws and regulations to qualify for their exemptions from enterprise income
tax or other income tax benefits (the “Tax Benefits”) as described in the
Registration Statement, the Time of Sale Disclosure Package and the Prospectus,
and the actual operations and business activities of each such PRC Entity are
sufficient to meet the qualifications for the Tax Benefits. No
submissions made to any PRC government authority in connection with obtaining
the Tax Benefits contained any misstatement or omission that would have affected
the granting of the Tax Benefits. No PRC Entity has received notice
of any deficiency in its respective applications for the Tax Benefits, and the
Company is not aware of any reason why any such PRC Entity might not qualify
for, or be in compliance with the requirements for, the Tax
Benefits.
(r) All
local and national PRC governmental tax holidays, exemptions, waivers, financial
subsidies, and other local and national PRC tax relief, concessions and
preferential treatment enjoyed by any PRC Entity as described in the
Registration Statement, the General Disclosure Package and the Prospectus are
valid, binding and enforceable and do not violate any laws, regulations, rules,
orders, decrees, guidelines, judicial interpretations, notices or other
legislation of the PRC.
(s) The
Underwriters will not be deemed to be resident, domiciled, carrying on business
or subject to taxation in the PRC solely by reason of its execution, delivery,
performance or enforcement of, or the consummation of any transaction
contemplated by, this Agreement, the Registration Statements, the General
Disclosure Package or the Prospectus.
Any
certificate signed by or on behalf of the Company and delivered to the
Representative or to counsel for the Underwriters shall be deemed to be a
representation and warranty by the Company to each Underwriter as to the matters
covered thereby.
3.
|
Purchase,
Sale and Delivery of Offered Securities. On the basis of
the representations, warranties and agreements herein contained, but
subject to the terms and conditions herein set forth, the Company agrees
to sell to the Underwriters, and the Underwriters agree, severally and not
jointly, to purchase from the Company the respective numbers of shares of
Firm Shares set forth opposite the names of the Underwriters in Schedule A
hereto.
|
The
purchase price per share to be paid by the Underwriters to the Company for the
Shares will be $6.5075 per share (the “Purchase Price”).
The
Company will deliver the Firm Shares to the Representative for the respective
accounts of the several Underwriters, through the facilities of The Depository
Trust Company in each such case, issued in such names and in such denominations
as the Representative may direct by notice in writing to the Company given at or
prior to 12:00 Noon, New York time, on the second (2nd) full
business day preceding the Firm Closing Date against payment of the aggregate
Purchase Price therefor by wire transfer in federal (same day) funds to an
account at a bank acceptable to the Representative payable to the order of the
Company at the offices of DLA Piper LLP (US), New York, New
York. Time shall be of the essence, and delivery at the time and
place specified pursuant to this Agreement is a further condition of the
obligations of each Underwriter hereunder. The time and date of the
delivery and closing shall be at 10:00 A.M., New York time, on December 7, 2009,
in accordance with Rule 15c6-1 of the Exchange Act. The time and date
of such payment and delivery are herein referred to as the “Firm Closing
Date.” The Firm Closing Date and the location of delivery of, and the
form of payment for, the Firm Shares may be varied by agreement between the
Company and the Representative.
For the
purpose of covering any over-allotments in connection with the distribution and
sale of the Firm Shares as contemplated by the Prospectus, the Underwriters may
purchase all or less than all of the Optional Shares. The price per
share to be paid for the Optional Shares shall be the Purchase
Price. The Company agrees to sell to the Underwriters the number of
shares of Optional Shares specified in the written notice delivered by the
Representative to the Company described below and the Underwriters agree,
severally and not jointly, to purchase such shares of Optional
Shares. The option granted hereby may be exercised as to all or any
part of the Optional Shares at any time, and from time to time, not more than
thirty (30) days subsequent to the date of this Agreement. No
Optional Shares shall be sold and delivered unless the Firm Shares previously
have been, or simultaneously are, sold and delivered. The right to
purchase the Optional Shares or any portion thereof may be surrendered and
terminated at any time upon notice by the Representative to the
Company.
- 16
-
The
option granted hereby may be exercised by written notice being given to the
Company by the Representative setting forth the number of shares of the Optional
Shares to be purchased by the Underwriters and the date and time for delivery of
and payment for the Optional Shares. Each date and time for delivery
of and payment for the Optional Shares (which may be the Closing Date, but not
earlier) is herein called the “Option Closing Date” and shall in no event be
earlier than two (2) business days nor later than five (5) business days after
written notice is given. The Firm Closing Date and the Option Closing
Date are each referred to herein as a “Closing Date” and collectively as the
“Closing Dates.”
The
Company will deliver the Optional Shares to the Representative for the
respective accounts of the several Underwriters through the facilities of The
Depository Trust Company, in each such case, issued in such names and in such
denominations as the Representative may direct by notice in writing to the
Company given at or prior to 12:00 Noon, New York time, on the second (2nd) full
business day preceding the Option Closing Date against payment of the
aggregate Purchase Price therefor by wire transfer in federal (same day) funds
to an account at a bank acceptable to the Representative payable to the order of
the Company all at the offices of DLA Piper LLP (US), New York, New
York. Time shall be of the essence, and delivery at the time and
place specified pursuant to this Agreement is a further condition of the
obligations of each Underwriter hereunder. The Option Closing Date
and the location of delivery of, and the form of payment for, the Optional
Shares may be varied by agreement between the Company and the
Representative.
The
several Underwriters propose to offer the Shares for sale upon the terms and
conditions set forth in the Prospectus.
4.
|
Further Agreements.
|
The
Company agrees with the several Underwriters:
(a) To
prepare the Rule 462(b) Registration Statement, if necessary, in a form approved
by the Representative and file such Rule 462(b) Registration Statement with the
Commission by 10:00 P.M., New York time, on the date hereof, and the Company
shall at the time of filing either pay to the Commission the filing fee for the
Rule 462(b) Registration Statement or give irrevocable instructions for the
payment of such fee pursuant to Rule 111(b) under the Rules and Regulations; to
prepare the Prospectus in a form approved by the Representative containing
information previously omitted at the time of effectiveness of the Registration
Statement in reliance on Rules 430A, 430B or 430C of the Rules and Regulations
and to file such Prospectus pursuant to Rule 424(b) of the Rules and Regulations
not later than the second business (2nd) day
following the execution and delivery of this Agreement or, if applicable, such
earlier time as may be required by Rule 430A of the Rules and Regulations; to
notify the Representative immediately of the Company’s intention to file or
prepare any supplement or amendment to any Registration Statement or to the
Prospectus and to make no amendment or supplement to the Registration
Statements, the General Disclosure Package or to the Prospectus to which the
Representative shall reasonably object by notice to the Company after a
reasonable period to review; to advise the Representative, promptly after it
receives notice thereof, of the time when any amendment to any Registration
Statement has been filed or becomes effective or any supplement to the General
Disclosure Package or the Prospectus or any amended Prospectus has been filed
and to furnish the Underwriters with copies thereof; to file promptly all
material required to be filed by the Company with the Commission pursuant to
Rules 433(d) or 163(b)(2) of the Rules and Regulations, as the case may be; to
file promptly all reports and any definitive proxy or information statements
required to be filed by the Company with the Commission pursuant to Section
13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the
Prospectus and for so long as the delivery of a prospectus (or in lieu thereof,
the notice referred to in Rule 173(a) of the Rules and Regulations) is required
in connection with the offering or sale of the Shares; to advise the
Representative, promptly after it receives notice thereof, of the issuance by
the Commission of any stop order or of any order preventing or suspending the
use of any Preliminary Prospectus, any Issuer Free Writing Prospectus or the
Prospectus, of the suspension of the qualification of the Shares for offering or
sale in any jurisdiction, of the initiation or threatening of any proceeding for
any such purpose, or of any request by the Commission for the amending or
supplementing of the Registration Statements, the General Disclosure Package or
the Prospectus or for additional information; and, in the event of the issuance
of any stop order or of any order preventing or suspending the use of any
Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus or
suspending any such qualification, and promptly to use its best efforts to
obtain the withdrawal of such order.
- 17
-
(b) The
Company represents and agrees that, unless it obtains the prior consent of the
Representative, it has not made and will not, make any offer relating to the
Shares that would constitute a “free writing prospectus” as defined in Rule 405
of the Rules and Regulations unless the prior written consent of the
Representative has been received (each, a “Permitted Free Writing Prospectus”);
provided that the prior
written consent of the Representative hereto shall be deemed to have been given
in respect of the Issuer Free Writing Prospectus included in Schedule B
hereof. The Company represents that it has treated and agrees that it
will treat each Permitted Free Writing Prospectus as an Issuer Free Writing
Prospectus, comply with the requirements of Rules 164 and 433 of the Rules and
Regulations applicable to any Issuer Free Writing Prospectus, including the
requirements relating to timely filing with the Commission, legending and record
keeping and will not take any action that would result in an Underwriter or the
Company being required to file with the Commission pursuant to Rule 433(d) of
the Rules and Regulations a free writing prospectus prepared by or on behalf of
such Underwriter that such Underwriter otherwise would not have been required to
file thereunder.
(c) [Intentionally
omitted]
(d) If
at any time when a prospectus relating to the Shares is required to be delivered
(or in lieu thereof, the notice referred to in Rule 173(a) of the Rules and
Regulations) any event occurs or condition exists as a result of which the
Prospectus as then amended or supplemented would include any untrue statement of
a material fact, or omit to state any material fact necessary to make the
statements therein, in light of the circumstances under which they were made
when the Prospectus is delivered (or in lieu thereof, the notice referred to in
Rule 173(a) of the Rules and Regulations), not misleading, or if it is necessary
at any time to amend or supplement any Registration Statement or the Prospectus
or to file under the Exchange Act any document incorporated by reference in the
Prospectus to comply with the Securities Act or the Exchange Act, that the
Company will promptly notify the Representative thereof and upon its request
will prepare an appropriate amendment or supplement or upon their request make
an appropriate filing pursuant to Section 13 or 14 of the Exchange Act in
form and substance approved by the Representative which will correct such
statement or omission or effect such compliance and will use its best efforts to
have any amendment to any Registration Statement declared effective as soon as
possible. The Company will furnish without charge to each Underwriter
and to any dealer in securities as many copies as the Representative may from
time to time reasonably request of such amendment or supplement. In
case any Underwriter is required to deliver a prospectus (or in lieu thereof,
the notice referred to in Rule 173(a) of the Rules and Regulations) relating to
the Shares, the Company upon the request of the Representative and at the
expense of such Underwriter will prepare promptly an amended or supplemented
Prospectus as may be necessary to permit compliance with the requirements of
Section 10(a)(3) of the Securities Act and deliver to such Underwriter as many
copies as such Underwriter may request of such amended or supplemented
Prospectus complying with Section 10(a)(3) of the Securities Act.
(e) If
the General Disclosure Package is being used to solicit offers to buy the Shares
at a time when the Prospectus is not yet available to prospective purchasers and
any event shall occur as a result of which, in the judgment of the Company or in
the reasonable opinion of the Underwriters, it becomes necessary to amend or
supplement the General Disclosure Package in order to make the statements
therein, in the light of the circumstances then prevailing, not misleading, or
to make the statements therein not conflict with the information contained or
incorporated by reference in the Registration Statement then on file and not
superseded or modified, or if it is necessary at any time to amend or supplement
the General Disclosure Package to comply with any law, the Company promptly will
either (i) prepare, file with the Commission (if required) and furnish to the
Underwriters and any dealers an appropriate amendment or supplement to the
General Disclosure Package (in a form reasonably approved by the Representative)
or (ii) prepare and file with the Commission an appropriate filing under the
Exchange Act (in a form reasonably approved by the Representative) which shall
be incorporated by reference in the General Disclosure Package so that the
General Disclosure Package as so amended or supplemented will not, in the light
of the circumstances then prevailing, be misleading or conflict with the
Registration Statement then on file, or so that the General Disclosure Package
will comply with law.
- 18
-
(f) If
at any time following issuance of an Issuer Free Writing Prospectus there
occurred or occurs an event or development as a result of which such Issuer Free
Writing Prospectus conflicted or will conflict with the information contained in
the Registration Statement, Pricing Prospectus or Prospectus, including any
document incorporated by reference therein and any prospectus supplement deemed
to be a part thereof and not superseded or modified or included or would include
an untrue statement of a material fact or omitted or would omit to state a
material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances prevailing at the
subsequent time, not misleading, the Company has promptly notified or will
promptly notify the Representative so that any use of the Issuer Free Writing
Prospectus may cease until it is amended or supplemented and has promptly
amended or will promptly amend or supplement (in a form reasonably approved by
the Representative), at its own expense, such Issuer Free Writing Prospectus to
eliminate or correct such conflict, untrue statement or omission.
(g) To
furnish promptly to the Representative and to counsel for the Underwriters a
signed copy of each of the Registration Statements as originally filed with the
Commission, and of each amendment thereto filed with the Commission, including
all consents and exhibits filed therewith.
(h) To
deliver promptly to the Representative such number of the following documents as
the Representative shall reasonably request: (i) conformed copies of
each Preliminary Prospectus, (ii) any Issuer Free Writing Prospectus, (iii) the
Prospectus (the delivery of the documents referred to in clauses (i), (ii) and
(iii) of this paragraph (h) to be made not later than 10:00 A.M., New York time,
on the business day following the execution and delivery of this Agreement),
(iv) conformed copies of any amendment to the Registration Statement (excluding
exhibits), and (v) any amendment or supplement to the General Disclosure Package
or the Prospectus (the delivery of the documents referred to in clauses (iv) and
(v) of this paragraph (h) to be made not later than 10:00 A.M., New York time,
on the business day following the date of such amendment or
supplement).
(i) To
make generally available to its shareholders as soon as practicable, but in any
event not later than sixteen (16) months after the effective date of each
Registration Statement (as defined in Rule 158(c) of the Rules and Regulations),
an earnings statement of the Company and its subsidiaries (which need not be
audited) complying with Section 11(a) of the Securities Act and the Rules and
Regulations (including, at the option of the Company, Rule 158).
(j) To
take promptly from time to time such actions as the Representative may
reasonably request to qualify the Shares for offering and sale under the
securities or Blue Sky laws of such jurisdictions (domestic or foreign) as the
Representative may designate and to continue such qualifications in effect, and
to comply with such laws, for so long as required to permit the offer and sale
of Shares in such jurisdictions; provided that the Company and
its subsidiaries shall not be obligated to qualify as foreign corporations in
any jurisdiction in which they are not so qualified or to file a general consent
to service of process in any jurisdiction.
(k) Upon
request, during the period of five (5) years from the date hereof, to deliver to
each of the Underwriters, (i) as soon as they are available, copies of all
reports or other communications furnished to shareholders, and (ii) as soon as
they are available, copies of any reports and financial statements furnished or
filed with the Commission or any national securities exchange on which the
Shares is listed. However, so long as the Company is subject to the
reporting requirements of either Section 13 or Section 15(d) of the Exchange Act
and is timely filing reports with the Commission on its Electronic Data
Gathering, Analysis and Retrieval system (“XXXXX”), it is not required to
furnish such reports or statements to the Underwriters.
- 19
-
(l) That
the Company will not, for a period of ninety (90) days from the date of this
Agreement, (the “Lock-Up Period”) without the prior written consent of Xxxx,
directly or indirectly offer, sell, assign, transfer, pledge, contract to sell,
or otherwise dispose of, or announce any intention to otherwise dispose of, any
shares of Common Stock or any securities convertible into or exercisable or
exchangeable for Common Stock, other than the Company’s sale of the Shares
hereunder and the
issuance of restricted Common Stock or options to acquire Common Stock pursuant
to the Company’s employee benefit plans, qualified stock option plans or other
employee compensation plans as such plans are in existence on the date hereof
and described in the Prospectus and the issuance of Common Stock pursuant to the
valid exercises of options, warrants or rights outstanding on the date hereof.
The Company will cause each officer, director, shareholder, optionholder and
warrantholder listed in Schedule D hereof to furnish to the Representative,
prior to the date of this Agreement, a letter, substantially in the form of
Exhibit I hereof, pursuant to which each such person shall agree, among other
things, not to directly or indirectly offer, sell, assign, transfer, pledge,
contract to sell, or otherwise dispose of, or announce the intention to
otherwise dispose of, any shares of Common Stock or any securities convertible
into or exercisable or exchangeable for Common Stock, not to engage in any swap,
hedge or similar agreement or arrangement that transfers, in whole or in part,
directly or indirectly, the economic risk of ownership of Common Stock or any
such securities and not to engage in any short selling of any Common Stock or
any such securities, during the Lock-Up Period, without the prior written
consent of Xxxx. The Company also agrees that during such period,
other than for the sale of the Shares hereunder, the Company will not file any
registration statement, preliminary prospectus or prospectus, or any amendment
or supplement thereto, under the Securities Act for any such transaction or
which registers, or offers for sale, Common Stock or any securities convertible
into or exercisable or exchangeable for Common Stock, except for a registration
statement on Form S-8 relating to employee benefit plans. The Company
hereby agrees that (i) if it issues an earnings release or material news, or if
a material event relating to the Company occurs, during the last seventeen (17)
days of the Lock-Up Period, or (ii) if prior to the expiration of the Lock-Up
Period, the Company announces that it will release earnings results during the
sixteen (16)-day period beginning on the last day of the Lock-Up Period, the
restrictions imposed by this paragraph (l)or the letter shall continue to apply
until the expiration of the eighteen (18)-day period beginning on the issuance
of the earnings release or the occurrence of the material news or material
event. The Company will provide Xxxx and any co-managers and each
stockholder subject to the Lock-Up Period with prior notice (in accordance with
Section 14 herein) of any such announcement that gives rise to an extension of
the Lock-Up Period. Notwithstanding the foregoing, after the date
hereof the Company shall be permitted to issue an aggregate of up to $5,000,000
of Common Stock to the Company’s executives and directors in a private placement
at a price per share not less than market value on the date of the private
placement, subject to compliance with applicable rules of the Commission and the
Exchange.
(m) To
supply the Representative with copies of all correspondence to and from, and all
documents issued to and by, the Commission in connection with the registration
of the Shares under the Securities Act or any of the Registration Statements,
any Preliminary Prospectus or the Prospectus, or any amendment or supplement
thereto or document incorporated by reference therein.
(n) Prior
to each of Closing Date, to furnish to the Representative, as soon as they have
been prepared, copies of any unaudited interim consolidated financial statements
of the Company for any periods subsequent to the periods covered by the
financial statements appearing in the Registration Statements and the
Prospectus.
(o) Prior
to the latest of the Closing Dates, not to issue any press release or other
communication directly or indirectly or hold any press conference with respect
to the Company, its condition, financial or otherwise, or earnings, business
affairs or business prospects (except for routine oral marketing communications
in the ordinary course of business and consistent with the past practices of the
Company and of which the Representative are notified), without the prior written
consent of the Representative, unless in the judgment of the Company and its
counsel, and after notification to the Representative, such press release or
communication is required by law.
(p) Until
the Representative shall have notified the Company of the completion of the
resale of the Shares, that the Company will not, and will cause its affiliated
purchasers (as defined in Regulation M under the Exchange Act) not to, either
alone or with one or more other persons, bid for or purchase, for any account in
which it or any of its affiliated purchasers has a beneficial interest, any
Shares, or attempt to induce any person to purchase any Shares; and not to, and
to cause its affiliated purchasers not to, make bids or purchase for the purpose
of creating actual, or apparent, active trading in or of raising the price of
the Shares.
- 20
-
(q) Not
to take any action prior to latest of the Closing Dates which would require the
Prospectus to be amended or supplemented pursuant to Section 4(d).
(r) To
at all times comply in all material respects with all applicable provisions of
the Xxxxxxxx-Xxxxx Act in effect from time to time.
(s) To
maintain, at its expense, a registrar and transfer agent for the
Shares.
(t) To
apply the net proceeds from the sale of the Shares as set forth in the General
Disclosure Package and the Prospectus under the heading “Use of Proceeds,” and
except as disclosed in the General Disclosure Package, the Company does not
intend to use any of the proceeds from the sale of the Shares hereunder to repay
any outstanding debt owed to any affiliate of any Underwriter. The
Company shall manage its affairs and investments in such a manner as not to be
or become an “investment company” within the meaning of the Investment Company
Act and the rules and regulations thereunder.
(u) To
use its best efforts to list, subject to notice of issuance, and to maintain the
listing of the Shares on the Exchange.
(v) To
use its best efforts to do and perform all things required to be done or
performed under this Agreement by the Company prior to each Closing Date and to
satisfy all conditions precedent to the delivery of the Firm Shares and the
Optional Shares.
5.
|
Payment
of Expenses. The Company agrees to pay, or reimburse if
paid by any Underwriter, whether or not the transactions contemplated
hereby are consummated or this Agreement is terminated: (a) the
costs incident to the authorization, issuance, sale, preparation and
delivery of the Shares and any taxes payable in that connection; (b) the
costs incident to the registration of the Shares under the Securities Act;
(c) the costs incident to the preparation, printing and distribution of
the Registration Statements, the Base Prospectus, any Preliminary
Prospectus, any Issuer Free Writing Prospectus, the General Disclosure
Package, the Prospectus, any amendments, supplements and exhibits thereto
or any document incorporated by reference therein and the costs of
printing, reproducing and distributing, the “Agreement Among Underwriters”
between the Representative and the Underwriters, the Master Selected
Dealers’ Agreement, the Underwriters’ Questionnaire, this Agreement and
any closing documents by mail, telex or other means of communications; (d)
the fees and expenses incurred in connection with securing any required
review by FINRA of the terms of the sale of the Shares and any filings
made with FINRA; (e) any applicable listing or other fees; (f) the fees
and expenses of qualifying the Shares under the securities laws of the
several jurisdictions as provided in Section (j)) and of preparing,
printing and distributing wrappers, Blue Sky Memoranda and Legal
Investment Surveys; (g) the cost of preparing and printing stock
certificates; (h) all fees and expenses of the registrar and transfer
agent of the Shares; (i) the costs and expenses of the Company relating to
investor presentations on any “road show” undertaken in connection with
the marketing of the offering of the Shares, including, without
limitation, expenses associated with the preparation or dissemination of
any electronic road show, expenses associated with the production of road
show slides and graphics, fees and expenses of any consultants engaged in
connection with the road show presentations with the prior approval of the
Company, travel and lodging expenses of the officers of the Company and
such consultants, including the cost of any aircraft chartered in
connection with the road show, and (j) all other costs and expenses
incident to the offering of the Shares or the performance of the
obligations of the Company under this Agreement (including, without
limitation, the fees and expenses of the Company’s counsel and the
Company’s independent accountants); provided that, except
to the extent otherwise provided in this Section 5 and in Section 7, the
Underwriters shall pay their own costs and expenses, including the fees
and expenses of their counsel, any transfer taxes on the resale of any
Shares by them and the expenses of advertising any offering of the Shares
made by the Underwriters.
|
- 21
-
6.
|
Conditions
of Underwriters’ Obligations. The respective obligations
of the several Underwriters hereunder are subject to the accuracy, when
made and as of the Applicable Time and on each Closing Date, of the
representations and warranties of the Company contained herein, to the
accuracy of the statements of the Company made in any certificates
pursuant to the provisions hereof, to the performance by the Company of
its obligations hereunder, and to each of the following additional terms
and conditions:
|
(a) The
Registration Statements have become effective under the Securities Act, and no
stop order suspending the effectiveness of any Registration Statement or any
part thereof, preventing or suspending the use of any Base Prospectus, any
Preliminary Prospectus, the Prospectus or any Permitted Free Writing Prospectus
or any part thereof shall have been issued and no proceedings for that purpose
or pursuant to Section 8A under the Securities Act shall have been initiated or
threatened by the Commission, and all requests for additional information on the
part of the Commission (to be included or incorporated by reference in the
Registration Statements or the Prospectus or otherwise) shall have been complied
with to the reasonable satisfaction of the Representative; the Rule 462(b)
Registration Statement, if any, each Issuer Free Writing Prospectus and the
Prospectus shall have been filed with, the Commission within the applicable time
period prescribed for such filing by, and in compliance with, the Rules and
Regulations and in accordance with Section 4(a), and the Rule 462(b)
Registration Statement, if any, shall have become effective immediately upon its
filing with the Commission; and FINRA shall have raised no objection to the
fairness and reasonableness of the terms of this Agreement or the transactions
contemplated hereby.
(b) None
of the Underwriters shall have discovered and disclosed to the Company on or
prior to such Closing Date that any Registration Statement or any amendment or
supplement thereto contains an untrue statement of a fact which, in the opinion
of counsel for the Underwriters, is material or omits to state any fact which,
in the opinion of such counsel, is material and is required to be stated therein
or is necessary to make the statements therein not misleading, or that the
General Disclosure Package, any Issuer Free Writing Prospectus or the Prospectus
or any amendment or supplement thereto contains an untrue statement of fact
which, in the opinion of such counsel, is material or omits to state any fact
which, in the opinion of such counsel, is material and is necessary in order to
make the statements, in the light of the circumstances in which they were made,
not misleading.
(c) All
corporate proceedings and other legal matters incident to the authorization,
form and validity of each of this Agreement, the Shares, the Registration
Statements, the General Disclosure Package, each Issuer Free Writing Prospectus
and the Prospectus and all other legal matters relating to this Agreement and
the transactions contemplated hereby shall be reasonably satisfactory in all
material respects to counsel for the Underwriters, and the Company shall have
furnished to such counsel all documents and information that they may reasonably
request to enable them to pass upon such matters.
(d) Loeb
& Loeb LLP, counsel for the Company, shall have furnished to the
Representative such counsel’s written opinion, as counsel to the Company,
addressed to the Underwriters and dated such Closing Date, in form and substance
satisfactory to the Representative, to the effect set forth in Annex A-1 to this
Agreement.
(e) Han
Kun Law Offices, PRC counsel for the Company, shall have furnished to the
Representative such counsel’s written opinion, as PRC counsel to the Company,
addressed to the Underwriters and dated such Closing Date, in form and substance
satisfactory to the Representative, to the effect set forth in Annex A-2 to this
Agreement.
(f) At
the time of the execution of this Agreement, the Representative shall have
received from each of Deloitte Touche Tohmatsu CPA Ltd. and Xxxxx X.X. Xxxxxx
& Co. a letter, addressed to the Underwriters, executed and dated such date,
in form and substance satisfactory to the Representative (i) confirming that
they are an independent registered accounting firm with respect to the Company
and its subsidiaries within the meaning of the Securities Act and the Rules and
Regulations and PCAOB and (ii) stating the conclusions and findings of such
firm, of the type ordinarily included in accountants’ “comfort letters” to
underwriters, with respect to the financial statements and certain financial
information contained or incorporated by reference in the Registration
Statements, the General Disclosure Package and the Prospectus.
(g) On
the effective date of any post-effective amendment to any Registration Statement
and on such Closing Date, the Representative shall have received a letter (the
“bring-down letter”) from each of Deloitte Touche Tohmatsu CPA Ltd. and Xxxxx
X.X. Xxxxxx & Co. addressed to the Underwriters and dated such Closing Date
confirming, as of the date of the bring-down letter (or, with respect to matters
involving changes or developments since the respective dates as of which
specified financial information is given in the General Disclosure Package and
the Prospectus, as the case may be, as of a date not more than three (3)
business days prior to the date of the bring-down letter), the conclusions and
findings of such firm, of the type ordinarily included in accountants’ “comfort
letters” to underwriters, with respect to the financial information and other
matters covered by its letter delivered to the Representative concurrently with
the execution of this Agreement pursuant to paragraph (f) of this Section
6.
- 22
-
(h) The
Company shall have furnished to the Representative a certificate, dated such
Closing Date, of its Chairman of the Board or President and its Chief Financial
Officer stating that (i) such officers have carefully examined the Registration
Statement, the General Disclosure Package, any Permitted Free Writing Prospectus
and the Prospectus and, in their opinion, the Registration Statements and each
amendment thereto, at the Applicable Time, as of the date of this Agreement and
as of such Closing Date did not include any untrue statement of a material fact
and did not omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading, and the General
Disclosure Package, as of the Applicable Time and as of such Closing Date, any
Permitted Free Writing Prospectus as of its date and as of such Closing Date,
the Prospectus and each amendment or supplement thereto, as of the respective
date thereof and as of such Closing Date, did not include any untrue statement
of a material fact and did not omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances in which they
were made, not misleading, (ii) since the effective date of the
Initial Registration Statement, no event has occurred which should have been set
forth in a supplement or amendment to the Registration Statements, the General
Disclosure Package or the Prospectus, and (iii) to the best of their knowledge
after reasonable investigation, as of such Closing Date, the representations and
warranties of the Company in this Agreement are true and correct in all material
respects (provided, however, that such materiality qualifier shall not be
applicable to any representation or warranty that is already qualified or
modified by materiality or Material Adverse Effect in the text thereof) and the
Company has complied with all agreements and satisfied all conditions on its
part to be performed or satisfied hereunder at or prior to such Closing
Date.
(i) There
has not been, subsequent to the date of the most recent audited financial
statements included or incorporated by reference in the General Disclosure
Package, any material adverse change in the financial position or results of
operations of the Company and its subsidiaries, or any change or development
that, singularly or in the aggregate, would involve a material adverse change or
a prospective material adverse change, in or affecting the condition (financial
or otherwise), results of operations, business, assets or prospects of the
Company and its subsidiaries taken as a whole, except as set forth in the
Prospectus.
(j) Since
the date of the latest financial statements included in the General Disclosure
Package or incorporated by reference in the General Disclosure Package as of the
date hereof, (i) neither the Company nor any of its subsidiaries shall have
sustained any loss or interference with its business from fire, explosion, flood
or other calamity, whether or not covered by insurance, or from any labor
dispute or court or governmental action, order or decree, otherwise than as set
forth in the General Disclosure Package, and (ii) there shall not have been any
change in the capital stock or long-term debt of the Company or any of its
subsidiaries, or any change, or any development involving a prospective change,
in or affecting the business, general affairs, management, financial position,
stockholders’ equity or results of operations of the Company and its
subsidiaries, otherwise than as set forth in the General Disclosure Package, the
effect of which, in any such case described in clause (i) or (ii) of this
paragraph (j), in the reasonable judgment of the Representative, is material and
adverse and makes it impracticable or inadvisable to proceed with the sale or
delivery of the Shares on the terms and in the manner contemplated in the
General Disclosure Package.
(k) No
action shall have been taken and no law, statute, rule, regulation or order
shall have been enacted, adopted or issued by any governmental agency or body
which would prevent the issuance or sale of the Shares or materially and
adversely affect or potentially materially and adversely affect the business or
operations of the Company; and no injunction, restraining order or order of any
other nature by any federal or state court of competent jurisdiction shall have
been issued which would prevent the issuance or sale of the Shares or materially
and adversely affect or potentially materially and adversely affect the business
or operations of the Company.
- 23
-
(l) Subsequent
to the execution and delivery of this Agreement (i) no downgrading shall have
occurred in the Company’s corporate credit rating or the rating accorded the
Company’s debt securities by any “nationally recognized statistical rating
organization,” as that term is defined by the Commission for purposes of Rule
436(g)(2) of the Rules and Regulations and (ii) no such organization shall have
publicly announced that it has under surveillance or review (other than an
announcement with positive implications of a possible upgrading), the Company’s
corporate credit rating or the rating of any of the Company’s debt
securities.
(m) Subsequent
to the execution and delivery of this Agreement there shall not have occurred
any of the following: (i) trading in securities generally on the New
York Stock Exchange, Nasdaq Global Market or the American Stock Exchange or in
the over-the-counter market, or trading in any securities of the Company on any
exchange or in the over-the-counter market, shall have been suspended or
materially limited, or minimum or maximum prices or maximum range for prices
shall have been established on any such exchange or such market by the
Commission, by such exchange or market or by any other regulatory body or
governmental authority having jurisdiction, (ii) a banking moratorium shall have
been declared by Federal or state authorities or a material disruption has
occurred in commercial banking or securities settlement or clearance services in
the United States, (iii) the United States shall have become engaged in
hostilities, or the subject of an act of terrorism, or there shall have been an
outbreak of or escalation in hostilities involving the United States, or there
shall have been a declaration of a national emergency or war by the United
States or (iv) there shall have occurred such a material adverse change in
general economic, political or financial conditions (or the effect of
international conditions on the financial markets in the United States shall be
such) as to make it, in the judgment of the Representative, impracticable or
inadvisable to proceed with the sale or delivery of the Shares on the terms and
in the manner contemplated in the General Disclosure Package and the
Prospectus.
(n) The
Exchange shall have approved the Shares for listing therein, subject only to
official notice of issuance.
(o) The
Representative shall have received on and as of such Closing Date satisfactory
evidence of the good standing of the Company and its subsidiaries in their
respective jurisdictions of organization and their good standing as foreign
entities in such other jurisdictions as the Representative may reasonably
request, in each case in writing or any standard form of telecommunication from
the appropriate Governmental Authorities of such jurisdictions.
(p) The
Representative shall have received the written agreements, substantially in the
form of Exhibit I hereto, of the officers, directors, shareholders,
optionholders and warrantholders of the Company listed in Schedule D to
this Agreement.
(q) On
or prior to such Closing Date, the Company shall have furnished to the
Representative such further certificates and documents as the Representative may
reasonably request.
All
opinions, letters, evidence and certificates mentioned above or elsewhere in
this Agreement shall be deemed to be in compliance with the provisions hereof
only if they are in form and substance reasonably satisfactory to counsel for
the Underwriters.
7.
|
Indemnification and
Contribution.
|
(a) The
Company shall indemnify and hold harmless each Underwriter, its directors,
officers, managers, members, employees, representatives and agents and each
person, if any, who controls any Underwriter within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act (collectively
the “Underwriter Indemnified Parties,” and each an “Underwriter Indemnified
Party”) against any loss, claim, damage, expense or liability whatsoever (or any
action, investigation or proceeding in respect thereof), joint or several, to
which such Underwriter Indemnified Party may become subject, under the
Securities Act or otherwise, insofar as such loss, claim, damage, expense,
liability, action, investigation or proceeding arises out of or is based upon
(A) any untrue statement or alleged untrue statement of a material fact
contained in any Preliminary Prospectus, any Issuer Free Writing Prospectus, any
“issuer information” filed or required to be filed pursuant to Rule 433(d) of
the Rules and Regulations, any Registration Statement or the Prospectus, or in
any amendment or supplement thereto or document incorporated by reference
therein, or in any materials or information provided to investors by, or with
the approval of, the Company in connection with the marketing of the offering of
the Shares, including any road show or investor presentations made to investors
by the Company (whether in person or electronically) (“Marketing Materials”), or
(B) the omission or alleged omission to state in any Preliminary Prospectus, any
Issuer Free Writing Prospectus, any “issuer information” filed or required to be
filed pursuant to Rule 433(d) of the Rules and Regulations, any Registration
Statement or the Prospectus, or in any amendment or supplement thereto or
document incorporated by reference therein or in any Marketing Materials, a
material fact required to be stated therein or necessary to make the statements
therein not misleading, or (C) in whole or in part upon any inaccuracy in the
representations and warranties of the Company contained herein or (D) in whole
or in part upon any failure of the Company to perform its obligations hereunder
or under law, and in each case shall reimburse each Underwriter Indemnified
Party promptly upon demand for any reasonable legal fees or other expenses
reasonably incurred by that Underwriter Indemnified Party in connection with
investigating, or preparing to defend, or defending against, or appearing as a
third party witness in respect of, or otherwise incurred in connection with, any
such loss, claim, damage, expense, liability, action, investigation or
proceeding, as such fees and expenses are incurred; provided, however, that the Company
shall not be liable in any such case to the extent that any such loss, claim,
damage, expense or liability arises out of or is based upon an untrue statement
or alleged untrue statement in, or omission or alleged omission from any
Preliminary Prospectus, any Registration Statement or the Prospectus, or any
such amendment or supplement thereto, or any Issuer Free Writing Prospectus made
in reliance upon and in conformity with written information furnished to the
Company through the Representative by or on behalf of any Underwriter
specifically for use therein, which information the parties hereto agree is
limited to the Underwriter’s Information (as defined in Section 17). The
indemnity agreement in this Section 7(a) is not exclusive and is in addition to
each other indemnity agreement in this Section 7(a) and each other liability
which the Company might have under this Agreement or otherwise, and shall not
limit any rights or remedies which may otherwise be available under this
Agreement, at law or in equity to any Underwriter Indemnified
Party.
- 24
-
(b) Each
Underwriter, severally and not jointly, shall indemnify and hold harmless the
Company and its directors, its officers who signed the Registration Statement
and each person, if any, who controls the Company within the meaning of Section
15 of the Securities Act or Section 20 of the Exchange Act (collectively the
“Company Indemnified Parties” and each a “Company Indemnified Party”) against
any loss, claim, damage, expense or liability whatsoever (or any action,
investigation or proceeding in respect thereof), joint or several, to which such
Company Indemnified Party may become subject, under the Securities Act or
otherwise, insofar as such loss, claim, damage, expense, liability, action,
investigation or proceeding arises out of or is based upon (i) any untrue
statement or alleged untrue statement of a material fact contained in any
Preliminary Prospectus, any Issuer Free Writing Prospectus, any “issuer
information” filed or required to be filed pursuant to Rule 433(d) of the Rules
and Regulations, any Registration Statement or the Prospectus, or in any
amendment or supplement thereto, or (ii) the omission or alleged omission to
state in any Preliminary Prospectus, any Issuer Free Writing Prospectus, any
“issuer information” filed or required to be filed pursuant to Rule 433(d) of
the Rules and Regulations, any Registration Statement or the Prospectus, or in
any amendment or supplement thereto, a material fact required to be stated
therein or necessary to make the statements therein not misleading, but in each
case only to the extent that the untrue statement or alleged untrue statement or
omission or alleged omission was made in reliance upon and in conformity with
written information furnished to the Company through the Representative by or on
behalf of that Underwriter specifically for use therein, which information the
parties hereto agree is limited to the Underwriter’s Information (as defined in
Section 17), and shall reimburse the Company Indemnified Parties for any
reasonable legal or other expenses reasonably incurred by such party in
connection with investigating or preparing to defend or defending against or
appearing as third party witness in connection with any such loss, claim,
damage, liability, action, investigation or proceeding, as such fees and
expenses are incurred. This indemnity agreement is not exclusive and
will be in addition to any liability which the Underwriters might otherwise have
and shall not limit any rights or remedies which may otherwise be available
under this Agreement, at law or in equity to the Company Indemnified
Parties.
- 25
-
(c) Promptly
after receipt by an indemnified party under this Section 7 of notice of the
commencement of any action, the indemnified party shall, if a claim in respect
thereof is to be made against an indemnifying party under this Section 7, notify
such indemnifying party in writing of the commencement of that action; provided, however, that the
failure to notify the indemnifying party shall not relieve it from any liability
which it may have under this Section 7 except to the extent it has been
materially prejudiced by such failure; and, provided, further, that the
failure to notify an indemnifying party shall not relieve it from any liability
which it may have to an indemnified party otherwise than under this Section
7. If any such action shall be brought against an indemnified party,
and it shall notify the indemnifying party thereof, the indemnifying party shall
be entitled to participate therein and, to the extent that it wishes, jointly
with any other similarly notified indemnifying party, to assume the defense of
such action with counsel reasonably satisfactory to the indemnified party (which
counsel shall not, except with the written consent of the indemnified party, be
counsel to the indemnifying party). After notice from the
indemnifying party to the indemnified party of its election to assume the
defense of such action, except as provided herein, the indemnifying party shall
not be liable to the indemnified party under Section 7 for any legal or other
expenses subsequently incurred by the indemnified party in connection with the
defense of such action other than reasonable costs of investigation; provided, however, that any
indemnified party shall have the right to employ separate counsel in any such
action and to participate in the defense of such action but the fees and
expenses of such counsel (other than reasonable costs of investigation) shall be
at the expense of such indemnified party unless (i) the employment thereof has
been specifically authorized in writing by the Company in the case of a claim
for indemnification under Section 7(a) or the Representative in the case of a
claim for indemnification under Section 7(a), (ii) such indemnified party shall
have been advised by its counsel that there may be one or more legal defenses
available to it which are different from or additional to those available to the
indemnifying party, or (iii) the indemnifying party has failed to assume the
defense of such action and employ counsel reasonably satisfactory to the
indemnified party within a reasonable period of time after notice of the
commencement of the action or the indemnifying party does not diligently defend
the action after assumption of the defense, in which case, if such indemnified
party notifies the indemnifying party in writing that it elects to employ
separate counsel at the expense of the indemnifying party, the indemnifying
party shall not have the right to assume the defense of (or, in the case of a
failure to diligently defend the action after assumption of the defense, to
continue to defend) such action on behalf of such indemnified party and the
indemnifying party shall be responsible for legal or other expenses subsequently
incurred by such indemnified party in connection with the defense of such
action; provided, however, that the
indemnifying party shall not, in connection with any one such action or separate
but substantially similar or related actions in the same jurisdiction arising
out of the same general allegations or circumstances, be liable for the
reasonable fees and expenses of more than one separate firm of attorneys at any
time for all such indemnified parties (in addition to any local counsel), which
firm shall be designated in writing by the Representative if the indemnified
parties under this Section 7 consist of any Underwriter Indemnified Party or by
the Company if the indemnified parties under this Section 7 consist of any
Company Indemnified Parties. Subject to this Section 7(c), the amount
payable by an indemnifying party under Section 7 shall include, but not be
limited to, (x) reasonable legal fees and expenses of counsel to the indemnified
party and any other expenses in investigating, or preparing to defend or
defending against, or appearing as a third party witness in respect of, or
otherwise incurred in connection with, any action, investigation, proceeding or
claim, and (y) all amounts paid in settlement of any of the
foregoing. No indemnifying party shall, without the prior written
consent of the indemnified parties, settle or compromise or consent to the entry
of judgment with respect to any pending or threatened action or any claim
whatsoever, in respect of which indemnification or contribution could be sought
under this Section 7 (whether or not the indemnified parties are actual or
potential parties thereto), unless such settlement, compromise or consent (i)
includes an unconditional release of each indemnified party in form and
substance reasonably satisfactory to such indemnified party from all liability
arising out of such action or claim and (ii) does not include a statement as to
or an admission of fault, culpability or a failure to act by or on behalf of any
indemnified party. Subject to the provisions of the following
sentence, no indemnifying party shall be liable for settlement of any pending or
threatened action or any claim whatsoever that is effected without its written
consent (which consent shall not be unreasonably withheld or delayed), but if
settled with its written consent, if its consent has been unreasonably withheld
or delayed or if there be a judgment for the plaintiff in any such matter, the
indemnifying party agrees to indemnify and hold harmless any indemnified party
from and against any loss or liability by reason of such settlement or
judgment. In addition, if at any time an indemnified party shall have
requested that an indemnifying party reimburse the indemnified party for fees
and expenses of counsel, such indemnifying party agrees that it shall be liable
for any settlement of the nature contemplated by Sections 7(a) or 7(b) effected
without its written consent if (i) such settlement is entered into more than
forty-five (45) days after receipt by such indemnifying party of the request for
reimbursement, (ii) such indemnifying party shall have received notice of the
terms of such settlement at least thirty (30) days prior to such settlement
being entered into and (iii) such indemnifying party shall not have
reimbursed such indemnified party in accordance with such request prior to the
date of such settlement.
- 26
-
(d) If
the indemnification provided for in this Section 7 is unavailable or
insufficient to hold harmless an indemnified party under Section 7(a), then each
indemnifying party shall, in lieu of indemnifying such indemnified party,
contribute to the amount paid, payable or otherwise incurred by such indemnified
party as a result of such loss, claim, damage, expense or liability (or any
action, investigation or proceeding in respect thereof), as incurred, (i) in
such proportion as shall be appropriate to reflect the relative benefits
received by the Company on the one hand and the Underwriters on the other from
the offering of the Shares, or (ii) if the allocation provided by clause (i) of
this Section 7(c) is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause (i)
of this Section 7(c) but also the relative fault of the Company on the one hand
and the Underwriters on the other with respect to the statements, omissions,
acts or failures to act which resulted in such loss, claim, damage, expense or
liability (or any action, investigation or proceeding in respect thereof) as
well as any other relevant equitable considerations. The relative
benefits received by the Company on the one hand and the Underwriters on the
other with respect to such offering shall be deemed to be in the same proportion
as the total net proceeds from the offering of the Shares purchased under this
Agreement (before deducting expenses) received by the Company bear to the total
underwriting discounts and commissions received by the Underwriters with respect
to the Shares purchased under this Agreement, in each case as set forth in the
table on the cover page of the Prospectus. The relative fault of the
Company on the one hand and the Underwriters on the other shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement
of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company on the one hand or the
Underwriters on the other, the intent of the parties and their relative
knowledge, access to information and opportunity to correct or prevent such
untrue statement, omission, act or failure to act; provided that the parties
hereto agree that the written information furnished to the Company through the
Representative by or on behalf of the Underwriters for use in the Preliminary
Prospectus, any Registration Statement or the Prospectus, or in any amendment or
supplement thereto, consists solely of the Underwriter’s Information (as defined
in Section 17).
(e) The
Company and the Underwriters agree that it would not be just and equitable if
contributions pursuant to Section 7(c) above were to be determined by
pro rata allocation (even if the Underwriters were treated as one entity for
such purpose) or by any other method of allocation which does not take into
account the equitable considerations referred to in Section 7(d)
above. The amount paid or payable by an indemnified party as a result
of the loss, claim, damage, expense, liability, action, investigation or
proceeding referred to in Section 7(d) above shall be deemed to include, subject
to the limitations set forth above, any legal or other expenses
reasonably incurred by such indemnified party in connection with investigating,
preparing to defend or defending against or appearing as a third party witness
in respect of, or otherwise incurred in connection with, any such loss, claim,
damage, expense, liability, action, investigation or
proceeding. Notwithstanding the provisions of this Section 7, no
Underwriter shall be required to contribute any amount in excess of the amount
by which the total price at which the Shares underwritten by it and distributed
to the public were offered to the public less the amount of any damages which
such Underwriter has otherwise paid or become liable to pay by reason of any
untrue or alleged untrue statement, omission or alleged omission, act or alleged
act or failure to act or alleged failure to act. No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any person who was not
guilty of such fraudulent misrepresentation. The Underwriters’
obligations to contribute as provided in this Section 7 are several in
proportion to their respective underwriting obligations and not
joint.
8.
|
Termination. The
obligations of the Underwriters hereunder may be terminated by the
Representative, in their absolute discretion by notice given to the
Company prior to delivery of and payment for the Firm Shares if, prior to
that time, any of the events described in Sections 6(h), 6(i), 6(j), 6(l)
or 6(m) have occurred or if the Underwriters shall decline to purchase the
Shares for any reason permitted under this
Agreement.
|
9.
|
[Intentionally
omitted]
|
- 27
-
10.
|
Substitution
of Underwriters. If any Underwriter or Underwriters
shall default in its or their obligations to purchase the Shares hereunder
on any Closing Date and the aggregate number of Shares which such
defaulting Underwriter or Underwriters agreed but failed to purchase does
not exceed ten percent (10%) of the total number of Shares to be purchased
by all Underwriters on such Closing Date, the other Underwriters shall be
obligated severally, in proportion to their respective commitments
hereunder, to purchase the Shares which such defaulting Underwriter or
Underwriters agreed but failed to purchase on such Closing
Date. If any Underwriter or Underwriters shall so default and
the aggregate number of Shares with respect to which such default or
defaults occur is more than ten percent (10%) of the total number of
Shares to be purchased by all Underwriters on such Closing Date and
arrangements satisfactory to the Representative and the Company for the
purchase of such Shares by other persons are not made within forty-eight
(48) hours after such default, this Agreement shall
terminate.
|
If the
remaining Underwriters or substituted Underwriters are required hereby or agree
to take up all or part of the Shares of a defaulting Underwriter or Underwriters
on such Closing Date as provided in this Section 10, (i) the Company shall
have the right to postpone such Closing Dates for a period of not more than five
(5) full business days in order that the Company may effect whatever changes may
thereby be made necessary in the Registration Statements or the Prospectus, or
in any other documents or arrangements, and the Company agrees promptly to file
any amendments to the Registration Statements or supplements to the Prospectus
which may thereby be made necessary, and (ii) the respective numbers of Shares
to be purchased by the remaining Underwriters or substituted Underwriters shall
be taken as the basis of their underwriting obligation for all purposes of this
Agreement. Nothing herein contained shall relieve any defaulting
Underwriter of its liability to the Company or the other Underwriters for
damages occasioned by its default hereunder. Any termination of this
Agreement pursuant to this Section 10 shall be without liability on the part of
any non-defaulting Underwriter or the Company, except that the representations,
warranties, covenants, indemnities, agreements and other statements set forth in
Section 2, the obligations with respect to expenses to be paid or reimbursed
pursuant to Section 5 and the provisions of Section 7 and Sections 11 through
21, inclusive, shall not terminate and shall remain in full force and
effect.
11
|
Absence
of Fiduciary Relationship. The Company acknowledges and agrees
that:
|
(a) each
Underwriter’s responsibility to the Company is solely contractual in nature, the
Representative have been retained solely to act as underwriters in connection
with the sale of the Shares and no fiduciary, advisory or agency relationship
between the Company and the Representative has been created in respect of any of
the transactions contemplated by this Agreement, irrespective of whether the
Representative has advised or is advising the Company on other
matters;
(b) the
price of the Shares set forth in this Agreement was established by the Company
following discussions and arms-length negotiations with the Representative, and
the Company is capable of evaluating and understanding, and understands and
accepts, the terms, risks and conditions of the transactions contemplated by
this Agreement;
(c) it
has been advised that the Representative and its affiliates are engaged in a
broad range of transactions which may involve interests that differ from those
of the Company and that the Representative has no obligation to disclose such
interests and transactions to the Company by virtue of any fiduciary, advisory
or agency relationship; and
(d) it
waives, to the fullest extent permitted by law, any claims it may have against
the Representative for breach of fiduciary duty or alleged breach of fiduciary
duty and agrees that the Representative shall have no liability (whether direct
or indirect) to the Company in respect of such a fiduciary duty claim or to any
person asserting a fiduciary duty claim on behalf of or in right of the Company,
including stockholders, employees or creditors of the Company.
12.
|
Successors;
Persons Entitled to Benefit of Agreement. This Agreement
shall inure to the benefit of and be binding upon the several
Underwriters, the Company and their respective successors and
assigns. Nothing expressed or mentioned in this Agreement is
intended or shall be construed to give any person, other than the persons
mentioned in the preceding sentence, any legal or equitable right, remedy
or claim under or in respect of this Agreement, or any provisions herein
contained, this Agreement and all conditions and provisions hereof being
intended to be and being for the sole and exclusive benefit of such
persons and for the benefit of no other person; except that the
representations, warranties, covenants, agreements and indemnities of the
Company contained in this Agreement shall also be for the benefit of the
Underwriter Indemnified Parties and the indemnities of the several
Underwriters shall be for the benefit of the Company Indemnified
Parties. It is understood that each Underwriter’s
responsibility to the Company is solely contractual in nature and the
Underwriters do not owe the Company, or any other party, any fiduciary
duty as a result of this Agreement. No purchaser of any of the
Shares from any Underwriter shall be deemed to be a successor or assign by
reason merely of such purchase.
|
- 28
-
13.
|
Survival
of Indemnities, Representations, Warranties, etc. The respective
indemnities, covenants, agreements, representations, warranties and other
statements of the Company and the several Underwriters, as set forth in
this Agreement or made by them respectively, pursuant to this Agreement,
shall remain in full force and effect, regardless of any investigation
made by or on behalf of any Underwriter, the Company or any person
controlling any of them and shall survive delivery of and payment for the
Shares. Notwithstanding any termination of this Agreement,
including without limitation any termination pursuant to Section 8 or
Section 10, the indemnities, covenants, agreements, representations,
warranties and other statements forth in Sections 2, 5, and 7 and Sections
11 through 21, inclusive, of this Agreement shall not terminate and shall
remain in full force and effect at all
times.
|
14.
|
Notices. All
statements, requests, notices and agreements hereunder shall be in
writing, and:
|
(a) if
to the Underwriters, shall be delivered or sent by mail, telex or facsimile
transmission to Xxxx Capital Partners, LLC, 00 Xxxxxxxxx Xxxxx, Xxxxxxx Xxxxx,
XX 00000, telecopy number: (000) 000-0000, Attention: Managing
Director; and
(b) if
to the Company shall be delivered or sent by mail, telex or facsimile
transmission to ChinaCast Education Corporation, Suite 08, 20F, One
International Financial Centre, No. 1 Harbour View Street, Central, Hong Kong,
Attention: Chief Executive Officer, Fax: x0 000 000 0000, or to ChinaCast
Education Corporation, c/o National Corporate Research, 000 Xxxxx Xxxxxx
Xxxxxxx, Xxxxx, Xxxxxxxx 00000; and
provided, however, that any
notice to an Underwriter pursuant to Section 7 shall be delivered or sent by
mail, or facsimile transmission to such Underwriter at its address
set forth in its acceptance telex to the Representative, which address will be
supplied to any other party hereto by the Representative upon
request. Any such statements, requests, notices or agreements shall
take effect at the time of receipt thereof.
15.
|
Definition
of Certain Terms. For purposes of this Agreement, (a)
“business day” means any day on which the Nasdaq Global Market is open for
trading and (b) “subsidiary” has the meaning set forth in Rule 405 of
the Rules and Regulations.
|
16.
|
Governing
Law, Agent For Service; Jurisdiction and Judgment Currency. This Agreement
shall be governed by and construed in accordance with the laws of the
State of New York. The Company irrevocably appoints
National Corporate Research, with offices at 000 Xxxxx Xxxxxx Xxxxxxx,
Xxxxx, Xxxxxxxx 00000 (and its successors) as
its authorized agent in the State of Delaware, upon which process may be
served in any such suit or proceeding, and agrees that service of process
upon such agent, and written notice of said service to the Company by the
person serving the same to the address provided in Section 14, shall be
deemed in every respect effective service of process upon the Company in
any such suit or proceeding. The Company irrevocably (a) submits to the
non-exclusive jurisdiction of the Federal and state courts in the State of
New York for the purpose of any suit, action or other proceeding arising
out of this Agreement or the transactions contemplated by this Agreement,
the Registration Statements and any Preliminary Prospectus or the
Prospectus, (b) agrees that all claims in respect of any such suit, action
or proceeding may be heard and determined by any such court, (c) waives to
the fullest extent permitted by applicable law, any immunity from the
jurisdiction of any such court or from any legal process, (d) agrees not
to commence any such suit, action or proceeding other than in such courts,
and (e) waives, to the fullest extent permitted by applicable law, any
claim that any such suit, action or proceeding is brought in an
inconvenient forum. The obligation of the Company, in respect of any sum
due to any Underwriter under this Agreement shall, notwithstanding any
judgment in a currency other than U.S. dollars or any other applicable
currency (the “Judgment Currency”), not be discharged until the first
business day, following receipt by such Underwriter of any sum adjudged to
be so due in the Judgment Currency, on which (and only to the extent that)
such Underwriter may in accordance with normal banking procedures purchase
U.S. dollars or any other applicable currency with the Judgment Currency;
if the U.S. dollars or other applicable currency so purchased are less
than the sum originally due to such Underwriter hereunder, the Company
agrees, as a separate obligation and notwithstanding any such judgment, to
indemnify such Underwriter against such loss. If the U.S. dollars or other
applicable currency so purchased are greater than the sum originally due
to such Underwriter hereunder, such Underwriter agrees to pay to the
Company an amount equal to the excess of the U.S. dollars or other
applicable currency so purchased over the sum originally due to such
Underwriter hereunder.
|
- 29
-
17.
|
Underwriters’
Information. The
parties hereto acknowledge and agree that, for all purposes of this
Agreement, the Underwriters’ Information consists solely of the following
information in the Prospectus: (i) the text in fourth paragraph
under the heading “Underwriting” concerning the terms of the offering by
the Underwriters and (ii) the text in the tenth and eleventh paragraphs
under the heading “Underwriting” concerning stabilizing transactions by
the Underwriters.
|
18.
|
Authority
of the Representative. In connection with this
Agreement, you will act for and on behalf of the several Underwriters, and
any action taken under this Agreement by the Representative, will be
binding on all the Underwriters.
|
19.
|
Partial
Unenforceability. The invalidity or unenforceability of
any section, paragraph, clause or provision of this Agreement shall not
affect the validity or enforceability of any other section, paragraph,
clause or provision hereof. If any section, paragraph, clause
or provision of this Agreement is for any reason determined to be invalid
or unenforceable, there shall be deemed to be made such minor changes (and
only such minor changes) as are necessary to make it valid and
enforceable.
|
20.
|
General. This
Agreement constitutes the entire agreement of the parties to this
Agreement and supersedes all prior written or oral and all contemporaneous
oral agreements, understandings and negotiations with respect to the
subject matter hereof. In this Agreement, the masculine,
feminine and neuter genders and the singular and the plural include one
another. The section headings in this Agreement are for the
convenience of the parties only and will not affect the construction or
interpretation of this Agreement. This Agreement may be amended
or modified, and the observance of any term of this Agreement may be
waived, only by a writing signed by the Company and the
Representative.
|
21.
|
Counterparts. This
Agreement may be signed in any number of counterparts, each of which shall
be an original, with the same effect as if the signatures thereto and
hereto were upon the same
instrument.
|
- 30
-
If the
foregoing is in accordance with your understanding of the agreement between the
Company and the several Underwriters, kindly indicate your acceptance in the
space provided for that purpose below.
Very
truly yours,
CHINACAST
EDUCATION CORPORATION
|
|||
|
By:
|
/s/ Xxx Xxxx Xxx Xxxx | |
Name: Xxx Xxxx Xxx Xxxx | |||
Title: Chief Executive Officer | |||
Accepted
as of
the
date first above written:
Xxxx
Capital Partners, LLC
|
||
Representative
of the several Underwriters
referred
to in the foregoing Agreement.
|
||
By:
|
Xxxx
Capital Partners, LLC
|
|
By:
|
/s/ Xxxxx X. Xxxxxxxx | |
Name:
Title:
|
Xxxxx
X. Xxxxxxxx
Head of Equity Capital Markets
|
- 31
-
SCHEDULE
A
Name
|
Number
of Shares of Firm Shares to be Purchased
|
Number
of Shares of Optional Shares to be Purchased
|
||||||
Xxxx
Capital Partners, LLC
|
5,337,000
|
800,550 | ||||||
Xxxxx
Xxxxxx, Carret & Co., LLC
|
296,500 | 44,475 | ||||||
Global
Hunter Securities, LLC
|
296,500 | 44,475 | ||||||
Total
|
5,930,000 | 889,500 |
SCHEDULE B
Permitted
Free Writing Prospectus
Final
Term Sheet dated December 1, 2009 as filed pursuant to Rule 433 under the
Act.
SCHEDULE C
Subsidiaries
SCHEDULE D
Xxx Xxxx
Xxx Xxxx
Xxxxxx
Xxxxxx
Xxxxxx
Xxxx
Xxxxxxx
Xxx
Xx
Xxx
Xxxxxxx
Xxxx
Xxxxxxx
Xxxxxx
Xxx
Ma
Exhibit
I
Form of
Lock-Up Agreement
November
[ ], 2009
Xxxx
Capital Partners, LLC
As
Representative of the several Underwriters
c/o Roth
Capital Partners, LLC
00
Xxxxxxxxx Xxxxx
Xxx Xxxx
Xxxxx, Xxxxxxxxxx 00000
Re: CHINACAST
EDUCATION CORPORATION – Registration Statement on Form S-3 for Shares of Common
Stock
Dear
Sirs:
This
Agreement is being delivered to you in connection with the proposed Underwriting
Agreement (the “Underwriting Agreement”) between ChinaCast Education
Corporation, a Delaware corporation (the “Company”) and Xxxx Capital Partners,
LLC (“Xxxx”), as representative of a group of underwriters (collectively, the
“Underwriters”), to be named therein, and the other parties thereto (if any),
relating to the proposed public offering of shares of the common stock, par
value $.0001 per share (the “Common Stock”) of the Company.
In order
to induce you and the other Underwriters to enter into the Underwriting
Agreement, and in light of the benefits that the offering of the Common Stock
will confer upon the undersigned in its capacity as a securityholder and/or an
officer, director or employee of the Company, and for good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the
undersigned agrees with each Underwriter that, during the period beginning on
the date hereof through and including the date that is the 90th day after the
date of the Underwriting Agreement (the “Lock-Up Period”), the undersigned will
not, without the prior written consent of Xxxx, directly or indirectly, (i)
offer, sell, assign, transfer, pledge, contract to sell, or otherwise dispose
of, or announce the intention to otherwise dispose of, any shares of Common
Stock (including, without limitation, Common Stock which may be deemed to be
beneficially owned by the undersigned in accordance with the rules and
regulations promulgated under the Securities Act of 1933, as the same may be
amended or supplemented from time to time (such shares, the “Beneficially Owned
Shares”)) or securities convertible into or exercisable or exchangeable for
Common Stock, (ii) enter into any swap, hedge or similar agreement or
arrangement that transfers in whole or in part, the economic risk of ownership
of the Beneficially Owned Shares or securities convertible into or exercisable
or exchangeable for Common Stock, whether now owned or hereafter acquired by the
undersigned or with respect to which the undersigned has or hereafter acquires
the power of disposition, or (iii) engage in any short selling of the Common
Stock or securities convertible into or exercisable or exchangeable for Common
Stock. If (i) the Company issues an earnings release or material news
or a material event relating to the Company occurs during the last 17 days of
the Lock-Up Period, or (ii) prior to the expiration of the Lock-Up Period, the
Company announces that it will release earnings results during the 16-day period
beginning on the last day of the Lock-Up Period, the Lock-Up Period shall be
extended and the restrictions imposed by this Agreement shall continue to apply
until the expiration of the 18-day period beginning on the issuance of the
earnings release or the occurrence of the material news or material
event.
The
restrictions set forth in the immediately preceding paragraph shall not apply
to:
(1) if
the undersigned is a natural person, any transfers made by the undersigned
(a) as a bona fide gift to any member of the immediate family (as defined
below) of the undersigned or to a trust the beneficiaries of which are
exclusively the undersigned or members of the undersigned’s immediate family,
(b) by will or intestate succession upon the death of the undersigned or
(c) as a bona fide gift to a charity or educational
institution,
(2) if
the undersigned is a corporation, partnership, limited liability company or
other business entity, any transfers to any shareholder, partner or member of,
or owner of a similar equity interest in, the undersigned, as the case may be,
if, in any such case, such transfer is not for value, and
(3) if
the undersigned is a corporation, partnership, limited liability company or
other business entity, any transfer made by the undersigned (a) in connection
with the sale or other bona fide transfer in a single transaction of all or
substantially all of the undersigned’s capital stock, partnership interests,
membership interests or other similar equity interests, as the case may be, or
all or substantially all of the undersigned’s assets, in any such case not
undertaken for the purpose of avoiding the restrictions imposed by this
agreement or (b) to another corporation, partnership, limited liability company
or other business entity so long as the transferee is an affiliate (as defined
below) of the undersigned and such transfer is not for value;
provided,
however, that in the case of any transfer described in clause (1), (2) or
(3) above, it shall be a condition to the transfer that (A) the
transferee executes and delivers to Xxxx, acting on behalf of the Underwriters,
not later than one business day prior to such transfer, a written agreement, in
substantially the form of this agreement (it being understood that any
references to “immediate family” in the agreement executed by such transferee
shall expressly refer only to the immediate family of the undersigned and not to
the immediate family of the transferee) and otherwise satisfactory in form and
substance to Xxxx, and (B) the undersigned shall not be required to file a
report under Section 16(a) of the Securities Exchange Act of 1934, as
amended, as a result of such transfer reporting a reduction in beneficial
ownership of shares of Common Stock or Beneficially Owned Shares or any
securities convertible into or exercisable or exchangeable for Common Stock or
Beneficially Owned Shares during the Lock-Up Period (as the same may be extended
as described above). For purposes of this paragraph, “immediate
family” shall mean a spouse, child, grandchild or other lineal descendant
(including by adoption), father, mother, brother or sister of the undersigned;
and “affiliate” shall have the meaning set forth in Rule 405 under the
Securities Act of 1933, as amended.
In order
to enable this covenant to be enforced, the undersigned hereby consents to the
placing of legends or stop transfer instructions with the Company’s transfer
agent with respect to any Common Stock or securities convertible into or
exercisable or exchangeable for Common Stock.
The
undersigned further agrees that (i) it will not, during the Lock-Up Period
(as the same may be extended as described above), make any demand or request for
or exercise any right with respect to the registration under the Securities Act
of 1933, as amended, of any shares of Common Stock or other Beneficially Owned
Shares or any securities convertible into or exercisable or exchangeable for
Common Stock or other Beneficially Owned Shares, and (ii) the Company may,
with respect to any Common Stock or other Beneficially Owned Shares or any
securities convertible into or exercisable or exchangeable for Common Stock or
other Beneficially Owned Shares owned or held (of record or beneficially) by the
undersigned, cause the transfer agent or other registrar to enter stop transfer
instructions and implement stop transfer procedures with respect to such
securities during the Lock-Up Period (as the same may be extended as described
above).
The
undersigned hereby represents and warrants that the undersigned has full power
and authority to enter into this agreement and that this agreement has been duly
authorized (if the undersigned is not a natural person), executed and delivered
by the undersigned and is a valid and binding agreement of the
undersigned. This agreement and all authority herein conferred are
irrevocable and shall survive the death or incapacity of the undersigned (if a
natural person) and shall be binding upon the heirs, personal representatives,
successors and assigns of the undersigned.
The
undersigned acknowledges and agrees that whether or not any public offering of
Common Stock actually occurs depends on a number of factors, including market
conditions.
Very
truly yours,
|
||
(Name
of Stockholder - Please Print)
|
||
(Signature)
|
||
(Name
of Signatory if Stockholder is an entity - Please
Print)
|
||
(Title
of Signatory if Stockholder is an entity - Please
Print)
|
||
Address:
|
||